Materiały źródłowe

• #1 Melanoma Skin Cancer Symptoms, Treatment | Froedtert & MCW

  https://www.froedtert.com/skin-cancer/melanoma

  Melanoma is one type of skin cancer. It can happen anywhere on your body including on the palms of the hands, bottoms of the feet and under the nails. […] While it is not as common as other types of skin cancer (1% of skin cancers are melanoma) melanoma is more aggressive and is more likely to spread to other parts of the body, including the lymph nodes, lungs, liver, bones or brain. It can grow very quickly and, in the most advanced stage, become life-threatening in as little as six weeks. But melanoma is highly curable when discovered and treated in its earliest stages. […] Melanoma can appear as a change in how a mole you already have looks (increase in size, change in color, shape, feel) or it can be a new area on the skin that looks and feels different. When melanoma becomes advanced, it can bleed, itch become painful or look raw or scraped.

• #2 Melanoma Skin Cancer – Summary, Symptoms, Treatments

  https://flcancer.com/articles/melanoma-skin-cancer/

  Melanoma is a serious type of skin cancer. It develops when melanocytes, the cells that give the skin its tan or brown color, start to grow out of control. These skin cancers generally start in the top layer of the skin, the epidermis, and grow slowly. They are most often found on areas of the skin that are exposed to the sun. […] Melanoma can develop anywhere on the skin, but usually starts on the chest and back in men and on the legs in women. When undetected, it can be fast-growing and can spread (metastasize) to other parts of the body, most often the nearby lymph nodes. […] The first warning signs of melanoma appear in moles that change in size, shape, color or feel. An easy way to recognize if a mole or other skin lesion may be cancerous is to review these ABCDE characteristics: A symmetry: one half of the mole does not match the other B order: is irregular C olor: is not uniform D iameter: greater than 6 mm (about the size of a pencil eraser) E volving: size, shape or color changes.

• #3 Melanoma | Causes, Symptoms & Treatments | Cancer Council

  https://www.cancer.org.au/cancer-information/types-of-cancer/melanoma

  Melanoma is a type of skin cancer that develops in the skin cells called melanocytes and usually occurs on the parts of the body that have been overexposed to the sun. Rare melanomas can occur inside the eye (ocular melanoma) or in parts of the skin or body that have never been exposed to the sun such as the palms of the hands, the soles of the feet or under the nails. […] Often melanoma has no symptoms, however, the first sign is generally a change in an existing mole or the appearance of a new spot. These changes can include: […] Other symptoms include dark areas under nails or on membranes lining the mouth, vagina or anus. […] Melanoma can vary in the way it looks. The first sign is usually a new spot or change in an existing mole. […] After being diagnosed with melanoma, you may feel shocked, upset, anxious or confused. These are normal responses. A diagnosis of melanoma affects each person differently. For most it will be a difficult time, however some people manage to continue with their normal daily activities.

• #4 Melanoma – Wikipedia

  https://en.wikipedia.org/wiki/Melanoma

  Melanoma is the most dangerous type of skin cancer; it develops from the melanin-producing cells known as melanocytes. It typically occurs in the skin, but may rarely occur in the mouth, intestines, or eye (uveal melanoma). In very rare cases melanoma can also happen in the lung which is known as primary pulmonary melanoma and only happens in 0.01% of primary lung tumors. […] Changes in a mole that can indicate melanoma include increase—especially rapid increase—in size, irregular edges, change in color, itchiness, or skin breakdown. […] Diagnosis is by biopsy and analysis of any skin lesion that has signs of being potentially cancerous. […] Treatment typically is removal by surgery of the melanoma and the potentially affected adjacent tissue bordering the melanoma. In those with slightly larger cancers, nearby lymph nodes may be tested for spread (metastasis). Most people are cured if metastasis has not occurred.

• #5 Melanoma Skin Cancer Symptoms, Treatment | Froedtert & MCW

  https://www.froedtert.com/skin-cancer/melanoma

  Melanoma is one type of skin cancer. It can happen anywhere on your body including on the palms of the hands, bottoms of the feet and under the nails. […] While it is not as common as other types of skin cancer (1% of skin cancers are melanoma) melanoma is more aggressive and is more likely to spread to other parts of the body, including the lymph nodes, lungs, liver, bones or brain. It can grow very quickly and, in the most advanced stage, become life-threatening in as little as six weeks. But melanoma is highly curable when discovered and treated in its earliest stages. […] Melanoma can appear as a change in how a mole you already have looks (increase in size, change in color, shape, feel) or it can be a new area on the skin that looks and feels different. When melanoma becomes advanced, it can bleed, itch become painful or look raw or scraped.

• #6 Melanoma Warning Signs and Images

  https://www.skincancer.org/skin-cancer-information/melanoma/melanoma-warning-signs-and-images/

  Finding melanoma at an early stage is crucial; early detection can vastly increase your chances for cure. […] Look for anything new, changing or unusual on both sun-exposed and sun-protected areas of the body. Melanomas commonly appear on the legs of women. The number one place they develop on men is the trunk. Keep in mind, though, that melanomas can arise anywhere on the skin, even in areas where the sun doesn’t shine. […] 99% 5-year survival rate for patients in the U.S. whose melanoma is detected early. The survival rate drops to 74% if the disease reaches the lymph nodes and 35% if it spreads to distant organs. […] A is for Asymmetry. Most melanomas are asymmetrical. If you draw a line through the middle of the lesion, the two halves don’t match, so it looks different from a round to oval and symmetrical common mole.

• #7 Metastatic Melanoma Stage 3 and 4 Symptoms, Survival Rate

  https://www.cancercenter.com/cancer-types/melanoma/types/metastatic-melanoma

  Stages 0, 1 and 2 are melanoma. Stage 3 (some cases) and stage 4 melanomas are considered metastatic melanomas. […] Once a melanoma has spread to distant parts of the body, such as the lungs, liver or other areas of skin, its considered stage 4. This cancer can be any thickness and may or may not have spread to nearby lymph nodes. […] The five-year survival rate for people diagnosed with melanoma that has spread to nearby lymph nodes is 66 percent, according to the American Cancer Society. When cancer has spread to distant parts of the body, there may also be other metastases too small to detect by scans. For people diagnosed with stage 4 melanoma, or melanoma that has spread to distant parts of the body, the five-year survival rate is 27 percent. […] According to the American Cancer Society, the five-year survival rate for people diagnosed with stage 3 melanoma that has spread to nearby lymph nodes or structures (regional spread) is 66 percent. For patients diagnosed with stage 4 melanoma (distant spread), the five-year survival rate is 27 percent. […] Stage 4 melanoma has a high likelihood of recurring and is considered difficult to treat.

• #8

  https://www.nhs.uk/conditions/melanoma-skin-cancer/symptoms/

  A new mole or a change in an existing mole may be signs of melanoma. […] Melanomas are often an uneven shape. They may have 2 different shaped halves and uneven edges. […] Melanomas are often a mix of 2 or more colours. […] Melanomas tend to be bigger, often more than 6mm wide. […] A mole that changes size, shape or colour may be a melanoma. […] Other signs to look out for include moles that are swollen and sore, bleeding, itchy, or crusty. […] Finding a melanoma as early as possible can mean it’s easier to treat.

• #9 Melanoma | Canadian Cancer Society

  https://cancer.ca/en/cancer-information/cancer-types/melanoma-skin

  Common signs and symptoms of melanoma skin cancer include a new mark on the skin and a mole that changes size, shape, colour or height. […] Melanoma skin cancer can spread (metastasize) to the lymph nodes, lung and liver. […] Prognosis estimates the outcome for melanoma skin cancer. It depends on many factors including the thickness of the tumour and how fast the cancer cells are growing.

• #10 Signs of Melanoma Skin Cancer | American Cancer Society

  https://www.cancer.org/cancer/types/melanoma-skin-cancer/detection-diagnosis-staging/signs-and-symptoms.html

  Unusual moles, sores, lumps, blemishes, markings, or changes in the way an area of the skin looks or feels may be a sign of melanoma or another type of skin cancer, or a warning that it might occur. […] The most important warning sign of melanoma is a new spot on the skin or a spot that is changing in size, shape, or color. […] Another important sign is a spot that looks different from all of the other spots on your skin. (This is sometimes known as „the ugly duckling sign.”) […] Its important to recognize changes in a mole’s size, shape, color, or texture. These changes could suggest a melanoma is developing. […] The ABCDE rule is another guide to the usual signs of melanoma. Be on the lookout and tell your doctor about spots that have any of the following features: A is for Asymmetry: One half of a mole or birthmark does not match the other. B is for Border: The edges are irregular, ragged, notched, or blurred. C is for Color: The color is not the same all over and may include different shades of brown or black, or sometimes with patches of pink, red, white, or blue. D is for Diameter: The spot is larger than 6 millimeters across (about inch the size of a pencil eraser), although melanomas can sometimes be smaller than this. E is for Evolving: The mole is changing in size, shape, or color.

• #11 Melanoma Warning Signs and Images

  https://www.skincancer.org/skin-cancer-information/melanoma/melanoma-warning-signs-and-images/

  Finding melanoma at an early stage is crucial; early detection can vastly increase your chances for cure. […] Look for anything new, changing or unusual on both sun-exposed and sun-protected areas of the body. Melanomas commonly appear on the legs of women. The number one place they develop on men is the trunk. Keep in mind, though, that melanomas can arise anywhere on the skin, even in areas where the sun doesn’t shine. […] 99% 5-year survival rate for patients in the U.S. whose melanoma is detected early. The survival rate drops to 74% if the disease reaches the lymph nodes and 35% if it spreads to distant organs. […] A is for Asymmetry. Most melanomas are asymmetrical. If you draw a line through the middle of the lesion, the two halves don’t match, so it looks different from a round to oval and symmetrical common mole.

• #12 Melanoma Warning Signs and Images

  https://www.skincancer.org/skin-cancer-information/melanoma/melanoma-warning-signs-and-images/

  B is for Border. Melanoma borders tend to be uneven and may have scalloped or notched edges. Common moles tend to have smoother, more even borders. […] C is for Color. Multiple colors are a warning sign. While benign moles are usually a single shade of brown, a melanoma may have different shades of brown, tan or black. As it grows, the colors red, white or blue may also appear. […] D is for Diameter or Dark. While it’s ideal to detect a melanoma when it is small, it’s a warning sign if a lesion is the size of a pencil eraser (about 6 mm, or ¼ inch in diameter) or larger. Some experts say it is important to look for any lesion, no matter what size, that is darker than others. Rare, amelanotic melanomas are colorless. […] E is for Evolving. Any change in size, shape, color or elevation of a spot on your skin, or any new symptom in it, such as bleeding, itching or crusting, may be a warning sign of melanoma.

• #13 Melanoma Warning Signs and Images

  https://www.skincancer.org/skin-cancer-information/melanoma/melanoma-warning-signs-and-images/

  B is for Border. Melanoma borders tend to be uneven and may have scalloped or notched edges. Common moles tend to have smoother, more even borders. […] C is for Color. Multiple colors are a warning sign. While benign moles are usually a single shade of brown, a melanoma may have different shades of brown, tan or black. As it grows, the colors red, white or blue may also appear. […] D is for Diameter or Dark. While it’s ideal to detect a melanoma when it is small, it’s a warning sign if a lesion is the size of a pencil eraser (about 6 mm, or ¼ inch in diameter) or larger. Some experts say it is important to look for any lesion, no matter what size, that is darker than others. Rare, amelanotic melanomas are colorless. […] E is for Evolving. Any change in size, shape, color or elevation of a spot on your skin, or any new symptom in it, such as bleeding, itching or crusting, may be a warning sign of melanoma.

• #14 Melanoma Warning Signs and Images

  https://www.skincancer.org/skin-cancer-information/melanoma/melanoma-warning-signs-and-images/

  B is for Border. Melanoma borders tend to be uneven and may have scalloped or notched edges. Common moles tend to have smoother, more even borders. […] C is for Color. Multiple colors are a warning sign. While benign moles are usually a single shade of brown, a melanoma may have different shades of brown, tan or black. As it grows, the colors red, white or blue may also appear. […] D is for Diameter or Dark. While it’s ideal to detect a melanoma when it is small, it’s a warning sign if a lesion is the size of a pencil eraser (about 6 mm, or ¼ inch in diameter) or larger. Some experts say it is important to look for any lesion, no matter what size, that is darker than others. Rare, amelanotic melanomas are colorless. […] E is for Evolving. Any change in size, shape, color or elevation of a spot on your skin, or any new symptom in it, such as bleeding, itching or crusting, may be a warning sign of melanoma.

• #15 Melanoma Warning Signs and Images

  https://www.skincancer.org/skin-cancer-information/melanoma/melanoma-warning-signs-and-images/

  B is for Border. Melanoma borders tend to be uneven and may have scalloped or notched edges. Common moles tend to have smoother, more even borders. […] C is for Color. Multiple colors are a warning sign. While benign moles are usually a single shade of brown, a melanoma may have different shades of brown, tan or black. As it grows, the colors red, white or blue may also appear. […] D is for Diameter or Dark. While it’s ideal to detect a melanoma when it is small, it’s a warning sign if a lesion is the size of a pencil eraser (about 6 mm, or ¼ inch in diameter) or larger. Some experts say it is important to look for any lesion, no matter what size, that is darker than others. Rare, amelanotic melanomas are colorless. […] E is for Evolving. Any change in size, shape, color or elevation of a spot on your skin, or any new symptom in it, such as bleeding, itching or crusting, may be a warning sign of melanoma.

• #16 Signs of Melanoma Skin Cancer | American Cancer Society

  https://www.cancer.org/cancer/types/melanoma-skin-cancer/detection-diagnosis-staging/signs-and-symptoms.html

  Other warning signs are: A sore that doesnt heal, Spread of pigment from the border of a spot into surrounding skin, Redness or a new swelling beyond the border of the mole, Change in sensation, such as itchiness, tenderness, or pain, Change in the surface of a mole scaliness, oozing, bleeding, or the appearance of a lump or bump. […] While most melanomas start on sun-exposed skin, a small portion of melanomas start in places that aren’t exposed to the sun. These might look different from melanomas on the skin.

• #17 Symptoms of melanoma skin cancer | Cancer Research UK

  https://www.cancerresearchuk.org/about-cancer/melanoma/symptoms

  Melanomas might change in size, shape or colour. Or you might notice other changes such as: […] bleeding […] itching […] a change in sensation to a mole or area of abnormal skin […] a mole becoming crusty. […] Most melanomas dont give you symptoms like pain or itching. And some non cancerous (benign) moles or abnormal patches of skin can be itchy. So having some of these changes on their own doesn’t mean you definitely have melanoma. But you should still get it checked. […] Melanoma in people with brown or black skin may be more difficult to see. The mole or abnormal patch of skin might: […] not show any of the ABCD signs […] be symmetrical […] be broken and sore (ulcerated) […] be a pink colour […] be under a finger or toe nail […] be on the palm of the hand or sole of the foot. […] The earlier a melanoma is picked up, the easier it is to treat and the more likely treatment is to be successful. So go to your GP as soon as possible.

• #18 Signs of Melanoma Skin Cancer | American Cancer Society

  https://www.cancer.org/cancer/types/melanoma-skin-cancer/detection-diagnosis-staging/signs-and-symptoms.html

  Unusual moles, sores, lumps, blemishes, markings, or changes in the way an area of the skin looks or feels may be a sign of melanoma or another type of skin cancer, or a warning that it might occur. […] The most important warning sign of melanoma is a new spot on the skin or a spot that is changing in size, shape, or color. […] Another important sign is a spot that looks different from all of the other spots on your skin. (This is sometimes known as „the ugly duckling sign.”) […] Its important to recognize changes in a mole’s size, shape, color, or texture. These changes could suggest a melanoma is developing. […] The ABCDE rule is another guide to the usual signs of melanoma. Be on the lookout and tell your doctor about spots that have any of the following features: A is for Asymmetry: One half of a mole or birthmark does not match the other. B is for Border: The edges are irregular, ragged, notched, or blurred. C is for Color: The color is not the same all over and may include different shades of brown or black, or sometimes with patches of pink, red, white, or blue. D is for Diameter: The spot is larger than 6 millimeters across (about inch the size of a pencil eraser), although melanomas can sometimes be smaller than this. E is for Evolving: The mole is changing in size, shape, or color.

• #19 Melanoma Warning Signs and Images

  https://www.skincancer.org/skin-cancer-information/melanoma/melanoma-warning-signs-and-images/

  Identifying a potential skin cancer is not easy, and not all melanomas follow the rules. Melanomas come in many forms and may display none of the typical warning signs. […] It’s also important to note that about 20 to 30 percent of melanomas develop in existing moles, while 70 to 80 percent arise on seemingly normal skin. […] The takeaway: Be watchful for any new mole or freckle that arises on your skin, a sore or spot that does not heal, any existing mole that starts changing (growing, swelling, itching) or any spot, mole or lesion that looks unusual.

• #20 Melanoma Signs & Symptoms | Memorial Sloan Kettering Cancer Center

  https://www.mskcc.org/cancer-care/types/melanoma/symptoms

  The first sign of melanoma is usually a changing, irregular spot on the skin that looks different from other spots. […] Melanoma can start in a mole that you’ve had for years, or it may be a new spot on the skin. […] Talk to your doctor if you notice a spot on your skin that is suspicious for melanoma. Melanoma is a serious condition. It is easier to treat when it is found early. […] Most early-stage melanoma exhibits one or several of the features described in Do U C Melanoma. As the disease progresses, the texture of the melanoma may change. The affected area may become hard or lumpy. It may also ooze or bleed, or be painful to the touch. […] In rare cases, melanoma may not have a brown or black color at all. It may look pink, red, or purple instead. These are called amelanotic melanomas because they lack the dark pigment, or melanin, that characterizes most melanomas. Amelanotic melanomas can be easily overlooked. They are often found later than melanomas with melanin pigment. That’s why it’s important to pay attention to any unusual spot on your skin regardless of color.

• #21 Melanoma Symptoms and Other Signs Besides Moles

  https://www.cancercenter.com/cancer-types/melanoma/symptoms

  Sometimes melanomas can be itchy. They may also bleed and ooze. […] Melanoma can be painful and tender to the touch, but you can also have melanoma without feeling any pain or discomfort. […] More than 90 percent of melanomas are thought to be caused by ultraviolet (UV) exposure, according to the U.S. Centers for Disease Control and Prevention. […] Melanoma may be found anywhere on the skin, but its most likely to develop on sun-exposed areas, namely the chest and back in men and the legs in women. The neck and face are also common sites for melanoma. […] If you have a darker skin type, you may be more likely to develop melanoma on your hands, the soles of your feet or under your nails. This is known as acral lentiginous melanoma and isnt caused by UV damage from the sun. It may differ in appearance from other types of melanoma.

• #22 Melanoma Symptoms and Other Signs Besides Moles

  https://www.cancercenter.com/cancer-types/melanoma/symptoms

  Sometimes melanomas can be itchy. They may also bleed and ooze. […] Melanoma can be painful and tender to the touch, but you can also have melanoma without feeling any pain or discomfort. […] More than 90 percent of melanomas are thought to be caused by ultraviolet (UV) exposure, according to the U.S. Centers for Disease Control and Prevention. […] Melanoma may be found anywhere on the skin, but its most likely to develop on sun-exposed areas, namely the chest and back in men and the legs in women. The neck and face are also common sites for melanoma. […] If you have a darker skin type, you may be more likely to develop melanoma on your hands, the soles of your feet or under your nails. This is known as acral lentiginous melanoma and isnt caused by UV damage from the sun. It may differ in appearance from other types of melanoma.

• #23 Melanoma Symptoms and Other Signs Besides Moles

  https://www.cancercenter.com/cancer-types/melanoma/symptoms

  Signs of acral lentiginous melanoma may include: A new line under your toenail or fingernail, A streak thats damaged the nail, A changing spot in or attached to a mole, A raised, thickened patch of skin on the sole of your foot or palm. […] The doctor will biopsy a mole if it looks suspicious, and the cells will be sent to a lab for analysis. If its melanoma, the patient may require surgery to remove the mole. If it has started to spread to other areas, chemotherapy and radiation, biologic and targeted therapies may also be recommended.

• #24 Melanoma Symptoms and Other Signs Besides Moles

  https://www.cancercenter.com/cancer-types/melanoma/symptoms

  Sometimes melanomas can be itchy. They may also bleed and ooze. […] Melanoma can be painful and tender to the touch, but you can also have melanoma without feeling any pain or discomfort. […] More than 90 percent of melanomas are thought to be caused by ultraviolet (UV) exposure, according to the U.S. Centers for Disease Control and Prevention. […] Melanoma may be found anywhere on the skin, but its most likely to develop on sun-exposed areas, namely the chest and back in men and the legs in women. The neck and face are also common sites for melanoma. […] If you have a darker skin type, you may be more likely to develop melanoma on your hands, the soles of your feet or under your nails. This is known as acral lentiginous melanoma and isnt caused by UV damage from the sun. It may differ in appearance from other types of melanoma.

• #25 Skin Cancer – BAD Patient Hub

  https://www.skinhealthinfo.org.uk/symptoms-treatments/skin-cancer/

  People with many (more than 50) ordinary moles, or with very large (greater than 20cm in diameter) dark hairy birthmarks, have a slightly higher than average chance of developing a melanoma. […] People with a suppressed immune system (e.g. as a result of an HIV infection or taking immunosuppressive drugs, perhaps after an organ transplant) have an increased chance of developing a melanoma. […] Acral lentiginous melanoma, or acral melanoma, is a type of skin cancer that can appear on the soles of the feet, the palms of the hands, and under the nails. It is much more common on the feet than on the hands. Acral melanomas form when skin pigment cells become cancerous and multiply in an uncontrolled way. […] Around 1 to 3% of melanoma cases are acral melanoma. It is the most common form of skin cancer in people with black or brown skin.

• #26 Internal melanoma symptoms & How to recognize them

  https://www.skinvision.com/library/internal-melanoma-symptoms

  Ocular melanoma is a very rare form of melanoma that appears as a dark spot on the iris, a change in the shape of the pupil, poor or blurry vision or causes flashing lights or floating specks. […] Mucosal melanoma can appear as sores that dont heal in your mouth or nasal passages, or in other areas of the body that produce mucus, such as the vagina and anus. If you notice any of these melanoma symptoms in these areas that dont heal and cannot be explained by other causes, visit your doctor as soon as possible. […] A particularly scary form of the illness occurs when melanoma forms in rare melanocyte cells in internal organs without any symptoms appearing on the skin. It can also occur when a tumor initially appeared on the skin but was fought off by the immune system, regressed and metastasized to another site inside the body. Unfortunately, no visible ways of detecting these rare occurrences of cancer are yet known. If melanoma has metastasized to internal parts of the body, cancer may exhibit advanced stage symptoms.

• #27 Internal melanoma symptoms & How to recognize them

  https://www.skinvision.com/library/internal-melanoma-symptoms

  Ocular melanoma is a very rare form of melanoma that appears as a dark spot on the iris, a change in the shape of the pupil, poor or blurry vision or causes flashing lights or floating specks. […] Mucosal melanoma can appear as sores that dont heal in your mouth or nasal passages, or in other areas of the body that produce mucus, such as the vagina and anus. If you notice any of these melanoma symptoms in these areas that dont heal and cannot be explained by other causes, visit your doctor as soon as possible. […] A particularly scary form of the illness occurs when melanoma forms in rare melanocyte cells in internal organs without any symptoms appearing on the skin. It can also occur when a tumor initially appeared on the skin but was fought off by the immune system, regressed and metastasized to another site inside the body. Unfortunately, no visible ways of detecting these rare occurrences of cancer are yet known. If melanoma has metastasized to internal parts of the body, cancer may exhibit advanced stage symptoms.

• #28

  https://winshipcancer.emory.edu/cancer-types-and-treatments/ocular-melanoma/symptoms.php

  Regular eye exams and familiarizing yourself with ocular melanoma symptoms are the keys to catching eye cancer early. […] The most common ocular melanoma symptoms include: Blurred vision, Floaters or vision spots, Loss of peripheral vision, Growing dark spot on the iris (colored part of eye), Changes to the pupil or eyeball, Eye bulging, Difficulty moving the eyeball. […] The sooner ocular melanoma is diagnosed, the better your prognosis may be.

• #29 Malignant Melanoma – StatPearls – NCBI BookshelfTwitterFacebookLinkedInGitHubNCBI Insights BlogTwitterFacebookYoutube

  https://www.ncbi.nlm.nih.gov/books/NBK470409/

  Melanoma treatment typically involves wide local excision, Mohs micrographic surgery, digital amputations, or adjuvant therapy depending on tumor location, depth, ulceration, lymph node involvement, and metastasis. […] The characteristic signs of early melanoma are recognized with the following well-known ABCDE mnemonic: “A” stands for Asymmetry, “B” stands for Border: irregular, ragged, notched, or blurred edges, “C” stands for Color: nonuniform or variegated, “D” stands for Diameter: larger than 6 millimeters, “E” stands for Evolving: changes in size, shape, or color. […] The following are the reported survival rates depending on the disease stage at diagnosis: Stage 0: 5-year overall survival rate of 99% to 100%, Stage IA: 5-year overall survival rate of 99%, Stage IB: 5-year overall survival rate of 97%, Stage IIA: 5-year overall survival rate of 94%, Stage IIB: 5-year overall survival rate of 87%, Stage IIC: 5-year overall survival rate of 82%, Stage IIIA: 5-year overall survival rate of 93%, Stage IIIB: 5-year overall survival rate of 83%, Stage IIIC: 5-year overall survival rate of 69%, Stage IIID: 5-year overall survival rate of 32%, Stage IV: 5-year overall survival rate of 34% to 52%.

• #30 Stages of Melanoma – AIM at Melanoma Foundation

  https://www.aimatmelanoma.org/stages-of-melanoma/

  Stage 0 melanoma, the malignant tumor is still confined to the upper layer of the skin. The cancer cells are only in the outer layer of the skin (the epidermis) and have not grown any deeper (into the dermis). The melanoma is in situ, which means “in place” in Latin. There is no evidence the cancer has spread to the lymph nodes or distant sites (metastasis). […] In Stage I melanoma, there are cancer cells in both the epidermis and dermis. A Stage I melanoma is up to 2mm thick (Breslow thickness) and may or may not have ulceration. There is no evidence the cancer has spread to lymph nodes or distant sites (metastasis). […] Stage II melanoma is defined by tumor thickness and ulceration. There are cancer cells in both the epidermis and dermis. There is no evidence the cancer has spread to the lymph nodes or distant sites (metastasis).

• #31 Malignant Melanoma – StatPearls – NCBI BookshelfTwitterFacebookLinkedInGitHubNCBI Insights BlogTwitterFacebookYoutube

  https://www.ncbi.nlm.nih.gov/books/NBK470409/

  Melanoma treatment typically involves wide local excision, Mohs micrographic surgery, digital amputations, or adjuvant therapy depending on tumor location, depth, ulceration, lymph node involvement, and metastasis. […] The characteristic signs of early melanoma are recognized with the following well-known ABCDE mnemonic: “A” stands for Asymmetry, “B” stands for Border: irregular, ragged, notched, or blurred edges, “C” stands for Color: nonuniform or variegated, “D” stands for Diameter: larger than 6 millimeters, “E” stands for Evolving: changes in size, shape, or color. […] The following are the reported survival rates depending on the disease stage at diagnosis: Stage 0: 5-year overall survival rate of 99% to 100%, Stage IA: 5-year overall survival rate of 99%, Stage IB: 5-year overall survival rate of 97%, Stage IIA: 5-year overall survival rate of 94%, Stage IIB: 5-year overall survival rate of 87%, Stage IIC: 5-year overall survival rate of 82%, Stage IIIA: 5-year overall survival rate of 93%, Stage IIIB: 5-year overall survival rate of 83%, Stage IIIC: 5-year overall survival rate of 69%, Stage IIID: 5-year overall survival rate of 32%, Stage IV: 5-year overall survival rate of 34% to 52%.

• #32 Stages of Melanoma – AIM at Melanoma Foundation

  https://www.aimatmelanoma.org/stages-of-melanoma/

  Stage 0 melanoma, the malignant tumor is still confined to the upper layer of the skin. The cancer cells are only in the outer layer of the skin (the epidermis) and have not grown any deeper (into the dermis). The melanoma is in situ, which means “in place” in Latin. There is no evidence the cancer has spread to the lymph nodes or distant sites (metastasis). […] In Stage I melanoma, there are cancer cells in both the epidermis and dermis. A Stage I melanoma is up to 2mm thick (Breslow thickness) and may or may not have ulceration. There is no evidence the cancer has spread to lymph nodes or distant sites (metastasis). […] Stage II melanoma is defined by tumor thickness and ulceration. There are cancer cells in both the epidermis and dermis. There is no evidence the cancer has spread to the lymph nodes or distant sites (metastasis).

• #33 Malignant Melanoma – StatPearls – NCBI BookshelfTwitterFacebookLinkedInGitHubNCBI Insights BlogTwitterFacebookYoutube

  https://www.ncbi.nlm.nih.gov/books/NBK470409/

  Melanoma treatment typically involves wide local excision, Mohs micrographic surgery, digital amputations, or adjuvant therapy depending on tumor location, depth, ulceration, lymph node involvement, and metastasis. […] The characteristic signs of early melanoma are recognized with the following well-known ABCDE mnemonic: “A” stands for Asymmetry, “B” stands for Border: irregular, ragged, notched, or blurred edges, “C” stands for Color: nonuniform or variegated, “D” stands for Diameter: larger than 6 millimeters, “E” stands for Evolving: changes in size, shape, or color. […] The following are the reported survival rates depending on the disease stage at diagnosis: Stage 0: 5-year overall survival rate of 99% to 100%, Stage IA: 5-year overall survival rate of 99%, Stage IB: 5-year overall survival rate of 97%, Stage IIA: 5-year overall survival rate of 94%, Stage IIB: 5-year overall survival rate of 87%, Stage IIC: 5-year overall survival rate of 82%, Stage IIIA: 5-year overall survival rate of 93%, Stage IIIB: 5-year overall survival rate of 83%, Stage IIIC: 5-year overall survival rate of 69%, Stage IIID: 5-year overall survival rate of 32%, Stage IV: 5-year overall survival rate of 34% to 52%.

• #34 Stages of Melanoma – AIM at Melanoma Foundation

  https://www.aimatmelanoma.org/stages-of-melanoma/

  Stage 0 melanoma, the malignant tumor is still confined to the upper layer of the skin. The cancer cells are only in the outer layer of the skin (the epidermis) and have not grown any deeper (into the dermis). The melanoma is in situ, which means “in place” in Latin. There is no evidence the cancer has spread to the lymph nodes or distant sites (metastasis). […] In Stage I melanoma, there are cancer cells in both the epidermis and dermis. A Stage I melanoma is up to 2mm thick (Breslow thickness) and may or may not have ulceration. There is no evidence the cancer has spread to lymph nodes or distant sites (metastasis). […] Stage II melanoma is defined by tumor thickness and ulceration. There are cancer cells in both the epidermis and dermis. There is no evidence the cancer has spread to the lymph nodes or distant sites (metastasis).

• #35 Malignant Melanoma – StatPearls – NCBI BookshelfTwitterFacebookLinkedInGitHubNCBI Insights BlogTwitterFacebookYoutube

  https://www.ncbi.nlm.nih.gov/books/NBK470409/

  Melanoma treatment typically involves wide local excision, Mohs micrographic surgery, digital amputations, or adjuvant therapy depending on tumor location, depth, ulceration, lymph node involvement, and metastasis. […] The characteristic signs of early melanoma are recognized with the following well-known ABCDE mnemonic: “A” stands for Asymmetry, “B” stands for Border: irregular, ragged, notched, or blurred edges, “C” stands for Color: nonuniform or variegated, “D” stands for Diameter: larger than 6 millimeters, “E” stands for Evolving: changes in size, shape, or color. […] The following are the reported survival rates depending on the disease stage at diagnosis: Stage 0: 5-year overall survival rate of 99% to 100%, Stage IA: 5-year overall survival rate of 99%, Stage IB: 5-year overall survival rate of 97%, Stage IIA: 5-year overall survival rate of 94%, Stage IIB: 5-year overall survival rate of 87%, Stage IIC: 5-year overall survival rate of 82%, Stage IIIA: 5-year overall survival rate of 93%, Stage IIIB: 5-year overall survival rate of 83%, Stage IIIC: 5-year overall survival rate of 69%, Stage IIID: 5-year overall survival rate of 32%, Stage IV: 5-year overall survival rate of 34% to 52%.

• #36 Stages of Melanoma – AIM at Melanoma Foundation

  https://www.aimatmelanoma.org/stages-of-melanoma/

  Stage III melanoma is defined by the level of lymph node involvement and ulceration. In Stage III melanoma, the cancer has spread to one or more regional lymph nodes or has developed a deposit of melanoma in the skin or dermis along the lymphatics prior to reaching a lymph node called an in transit or satellite metastasis. There is no evidence the cancer has spread to distant sites (metastasis). […] In Stage IV melanoma, the cancer has spread beyond the original tumor site and regional lymph nodes to more distant areas of the body. The most common sites of metastasis are distant skin and lymph nodes, then lungs, liver, brain, bone, and/or intestines. The level of serum lactate dehydrogenase (LDH) may or may not be elevated. […] Brain metastases, a specific form of Stage IV melanoma, are one of the most common and difficult-to-treat complications of melanoma. They differ from all other metastases in terms of risk factors, diagnosis, and treatment.

• #37 Malignant Melanoma – StatPearls – NCBI BookshelfTwitterFacebookLinkedInGitHubNCBI Insights BlogTwitterFacebookYoutube

  https://www.ncbi.nlm.nih.gov/books/NBK470409/

  Melanoma treatment typically involves wide local excision, Mohs micrographic surgery, digital amputations, or adjuvant therapy depending on tumor location, depth, ulceration, lymph node involvement, and metastasis. […] The characteristic signs of early melanoma are recognized with the following well-known ABCDE mnemonic: “A” stands for Asymmetry, “B” stands for Border: irregular, ragged, notched, or blurred edges, “C” stands for Color: nonuniform or variegated, “D” stands for Diameter: larger than 6 millimeters, “E” stands for Evolving: changes in size, shape, or color. […] The following are the reported survival rates depending on the disease stage at diagnosis: Stage 0: 5-year overall survival rate of 99% to 100%, Stage IA: 5-year overall survival rate of 99%, Stage IB: 5-year overall survival rate of 97%, Stage IIA: 5-year overall survival rate of 94%, Stage IIB: 5-year overall survival rate of 87%, Stage IIC: 5-year overall survival rate of 82%, Stage IIIA: 5-year overall survival rate of 93%, Stage IIIB: 5-year overall survival rate of 83%, Stage IIIC: 5-year overall survival rate of 69%, Stage IIID: 5-year overall survival rate of 32%, Stage IV: 5-year overall survival rate of 34% to 52%.

• #38 Stages of Melanoma – AIM at Melanoma Foundation

  https://www.aimatmelanoma.org/stages-of-melanoma/

  Stage III melanoma is defined by the level of lymph node involvement and ulceration. In Stage III melanoma, the cancer has spread to one or more regional lymph nodes or has developed a deposit of melanoma in the skin or dermis along the lymphatics prior to reaching a lymph node called an in transit or satellite metastasis. There is no evidence the cancer has spread to distant sites (metastasis). […] In Stage IV melanoma, the cancer has spread beyond the original tumor site and regional lymph nodes to more distant areas of the body. The most common sites of metastasis are distant skin and lymph nodes, then lungs, liver, brain, bone, and/or intestines. The level of serum lactate dehydrogenase (LDH) may or may not be elevated. […] Brain metastases, a specific form of Stage IV melanoma, are one of the most common and difficult-to-treat complications of melanoma. They differ from all other metastases in terms of risk factors, diagnosis, and treatment.

• #39 Metastatic Melanoma Stage 3 and 4 Symptoms, Survival Rate

  https://www.cancercenter.com/cancer-types/melanoma/types/metastatic-melanoma

  Stages 0, 1 and 2 are melanoma. Stage 3 (some cases) and stage 4 melanomas are considered metastatic melanomas. […] Once a melanoma has spread to distant parts of the body, such as the lungs, liver or other areas of skin, its considered stage 4. This cancer can be any thickness and may or may not have spread to nearby lymph nodes. […] The five-year survival rate for people diagnosed with melanoma that has spread to nearby lymph nodes is 66 percent, according to the American Cancer Society. When cancer has spread to distant parts of the body, there may also be other metastases too small to detect by scans. For people diagnosed with stage 4 melanoma, or melanoma that has spread to distant parts of the body, the five-year survival rate is 27 percent. […] According to the American Cancer Society, the five-year survival rate for people diagnosed with stage 3 melanoma that has spread to nearby lymph nodes or structures (regional spread) is 66 percent. For patients diagnosed with stage 4 melanoma (distant spread), the five-year survival rate is 27 percent. […] Stage 4 melanoma has a high likelihood of recurring and is considered difficult to treat.

• #40 Malignant Melanoma – StatPearls – NCBI BookshelfTwitterFacebookLinkedInGitHubNCBI Insights BlogTwitterFacebookYoutube

  https://www.ncbi.nlm.nih.gov/books/NBK470409/

  Melanoma treatment typically involves wide local excision, Mohs micrographic surgery, digital amputations, or adjuvant therapy depending on tumor location, depth, ulceration, lymph node involvement, and metastasis. […] The characteristic signs of early melanoma are recognized with the following well-known ABCDE mnemonic: “A” stands for Asymmetry, “B” stands for Border: irregular, ragged, notched, or blurred edges, “C” stands for Color: nonuniform or variegated, “D” stands for Diameter: larger than 6 millimeters, “E” stands for Evolving: changes in size, shape, or color. […] The following are the reported survival rates depending on the disease stage at diagnosis: Stage 0: 5-year overall survival rate of 99% to 100%, Stage IA: 5-year overall survival rate of 99%, Stage IB: 5-year overall survival rate of 97%, Stage IIA: 5-year overall survival rate of 94%, Stage IIB: 5-year overall survival rate of 87%, Stage IIC: 5-year overall survival rate of 82%, Stage IIIA: 5-year overall survival rate of 93%, Stage IIIB: 5-year overall survival rate of 83%, Stage IIIC: 5-year overall survival rate of 69%, Stage IIID: 5-year overall survival rate of 32%, Stage IV: 5-year overall survival rate of 34% to 52%.

• #41 Stages of Melanoma – AIM at Melanoma Foundation

  https://www.aimatmelanoma.org/stages-of-melanoma/

  Stage III melanoma is defined by the level of lymph node involvement and ulceration. In Stage III melanoma, the cancer has spread to one or more regional lymph nodes or has developed a deposit of melanoma in the skin or dermis along the lymphatics prior to reaching a lymph node called an in transit or satellite metastasis. There is no evidence the cancer has spread to distant sites (metastasis). […] In Stage IV melanoma, the cancer has spread beyond the original tumor site and regional lymph nodes to more distant areas of the body. The most common sites of metastasis are distant skin and lymph nodes, then lungs, liver, brain, bone, and/or intestines. The level of serum lactate dehydrogenase (LDH) may or may not be elevated. […] Brain metastases, a specific form of Stage IV melanoma, are one of the most common and difficult-to-treat complications of melanoma. They differ from all other metastases in terms of risk factors, diagnosis, and treatment.

• #42 7 Melanoma Symptoms (Plus Images) to Watch For

  https://www.molemap.co.nz/melanoma/symptoms

  Generally, benign moles or skin lesions dont change. Or if they do, the change happens slowly over several years. In comparison, a nodular melanoma tends to grow quickly. Changes can be seen within days or weeks. […] Its important to regularly scan your skin and look for any spots that are: sore, scaly, itchy, bleeding, tender and dont heal within 6 weeks. […] If you spot an ugly duckling mole, we recommend you see your GP or seek a skin check or mole check from a MoleMap skin cancer detection clinic near you. […] If you have olive or dark skin, your risk is reduced. But remember, low risk doesnt mean NO risk. People with darker skin can still get melanoma. […] We know that it can be a bit scary finding a suspicious mole in case it turns out to be melanoma. Melanoma is fast-growing and, if left untreated, it can spread to the lymph nodes.

• #43 Melanoma: Signs and Symptoms

  https://www.health.com/melanoma-symptoms-8399742

  Symptoms of lentigo maligna melanomas usually occur on the face or other areas of skin that are repeatedly exposed to or damaged by the sun. These tumors are most likely to grow gradually over time on older people. […] This type of melanoma usually appears on the palms of the hands, on the bottom of the feet, or beneath the nails. […] Noticing and reporting any changes to your skin is key to catching melanoma early and treating it successfully. […] If the cancer is caught and treated early, the large majority of people with melanoma will survive. […] However, if melanoma spreads to other parts of the body without early detection, the likelihood of survival decreases greatly. […] Melanoma symptoms can spread at different rates depending on the type of melanoma. Some types of melanoma, such as lentigo maligna melanoma, tend to be slow growing. Other types, such as nodular melanoma, tend to grow more rapidly. […] Most cases of melanoma cause no symptoms aside from a new or changing spot on the skin. If a melanoma goes untreated and spreads to other parts of the body, however, it may cause other symptoms.

• #44 Malignant Melanoma – StatPearls – NCBI BookshelfTwitterFacebookLinkedInGitHubNCBI Insights BlogTwitterFacebookYoutube

  https://www.ncbi.nlm.nih.gov/books/NBK470409/

  Melanoma is a malignancy derived from the malignant transformation of melanocytes. […] The 5-year relative survival rate for patients with stage 0 melanoma or melanoma-in-situ is 97%, compared to 30% for those with stage IV disease. […] Once a suspicious skin lesion is identified, a biopsy must be performed to confirm the diagnosis of melanoma. […] Patients typically present with an asymmetrical large lesion that may also itch, bleed, ulcerate, or develop satellite lesions. […] An individual’s risk of metastasis is directly related to the depth of invasion and ulceration of the primary lesion. […] The early stages of cancer metastasis involve invasion, angiogenesis, extravasation, dissemination, and colonization of the target organ. […] Patients who present with metastatic disease or with primary sites other than the skin have signs and symptoms related to the affected organ systems.

• #45 Symptoms of advanced melanoma skin cancer | Cancer Research UK

  https://www.cancerresearchuk.org/about-cancer/melanoma/advanced-melanoma/symptoms-advanced-melanoma

  Advanced melanoma skin cancer means it has spread to another part of the body such as the liver, lungs or bone. […] Some people may not get symptoms when they have advanced cancer. Their doctor may find the cancer has spread during a scan for a follow up appointment. If they do have symptoms, these will depend on where the cancer has spread to. […] The symptoms of advanced cancer depend on where the cancer is in your body. But general symptoms might include: hard or swollen lymph nodes, a hard lump on your skin, unexplained pain, feeling very tired or unwell, unexplained weight loss. […] If the cancer has spread to your lymph nodes they can feel hard or swollen. Swollen lymph nodes in the neck area can make it hard to swallow. […] You may have any of these symptoms if your cancer has spread into the lungs: a cough that doesn’t go away, breathlessness, ongoing chest infections, coughing up blood, a buildup of fluid between the chest wall and the lung (a pleural effusion).

• #46 Symptoms of advanced melanoma skin cancer | Cancer Research UK

  https://www.cancerresearchuk.org/about-cancer/melanoma/advanced-melanoma/symptoms-advanced-melanoma

  Advanced melanoma skin cancer means it has spread to another part of the body such as the liver, lungs or bone. […] Some people may not get symptoms when they have advanced cancer. Their doctor may find the cancer has spread during a scan for a follow up appointment. If they do have symptoms, these will depend on where the cancer has spread to. […] The symptoms of advanced cancer depend on where the cancer is in your body. But general symptoms might include: hard or swollen lymph nodes, a hard lump on your skin, unexplained pain, feeling very tired or unwell, unexplained weight loss. […] If the cancer has spread to your lymph nodes they can feel hard or swollen. Swollen lymph nodes in the neck area can make it hard to swallow. […] You may have any of these symptoms if your cancer has spread into the lungs: a cough that doesn’t go away, breathlessness, ongoing chest infections, coughing up blood, a buildup of fluid between the chest wall and the lung (a pleural effusion).

• #47 Symptoms and Pictures of Stage 4 Melanoma

  https://www.healthline.com/health/cancer/stage-4-melanoma-pictures

  What does a stage 4 diagnosis of melanoma mean? […] Stage 4 is the most advanced phase of melanoma, a serious form of skin cancer. This means the cancer has spread from the lymph nodes to other organs, most often the lungs. Some doctors also refer to stage 4 melanoma as advanced melanoma. […] A change to an existing mole or skin can be the first sign that the cancer has spread. But the physical symptoms of stage 4 melanoma aren’t the same for everyone. […] When melanoma spreads to nearby lymph nodes, those nodes may become matted or joined together. When you press on the matted lymph nodes, they will feel lumpy and hard. […] The size of the tumor isn’t always the best indicator of skin cancer staging. But the American Joint Commission on Cancer reports that stage 4 melanoma tumors tend to be thicker more than 4 millimeters deep.

• #48 Symptoms of advanced melanoma skin cancer | Cancer Research UK

  https://www.cancerresearchuk.org/about-cancer/melanoma/advanced-melanoma/symptoms-advanced-melanoma

  Advanced melanoma skin cancer means it has spread to another part of the body such as the liver, lungs or bone. […] Some people may not get symptoms when they have advanced cancer. Their doctor may find the cancer has spread during a scan for a follow up appointment. If they do have symptoms, these will depend on where the cancer has spread to. […] The symptoms of advanced cancer depend on where the cancer is in your body. But general symptoms might include: hard or swollen lymph nodes, a hard lump on your skin, unexplained pain, feeling very tired or unwell, unexplained weight loss. […] If the cancer has spread to your lymph nodes they can feel hard or swollen. Swollen lymph nodes in the neck area can make it hard to swallow. […] You may have any of these symptoms if your cancer has spread into the lungs: a cough that doesn’t go away, breathlessness, ongoing chest infections, coughing up blood, a buildup of fluid between the chest wall and the lung (a pleural effusion).

• #49 Signs and symptoms of advanced melanoma | Macmillan Cancer Support

  https://www.macmillan.org.uk/cancer-information-and-support/melanoma/advanced-melanoma/signs-and-symptoms-of-advanced-melanoma

  Advanced melanoma can cause different symptoms. This depends on where in the body melanoma has spread to. […] You may notice a lump and the lymph nodes may feel hard and swollen. Sometimes, they press on tissues or nerves nearby, causing pain. […] Melanoma that spreads to areas of skin far away from the original melanoma appears as firm or hard lumps called nodules. Or there may be flat, grey or purple areas of skin. These lumps or areas may bleed. […] If melanoma spreads to the lungs, it may cause symptoms such as breathlessness, a cough, and coughing up blood. […] Melanoma that has spread to the brain may cause headaches and sickness. These can be worse first thing in the morning. Other symptoms depend on the area of the brain affected. They may include numbness or weakness in a limb, or having a seizure (fit).

• #50 Signs and symptoms of advanced melanoma | Macmillan Cancer Support

  https://www.macmillan.org.uk/cancer-information-and-support/melanoma/advanced-melanoma/signs-and-symptoms-of-advanced-melanoma

  Advanced melanoma can cause different symptoms. This depends on where in the body melanoma has spread to. […] You may notice a lump and the lymph nodes may feel hard and swollen. Sometimes, they press on tissues or nerves nearby, causing pain. […] Melanoma that spreads to areas of skin far away from the original melanoma appears as firm or hard lumps called nodules. Or there may be flat, grey or purple areas of skin. These lumps or areas may bleed. […] If melanoma spreads to the lungs, it may cause symptoms such as breathlessness, a cough, and coughing up blood. […] Melanoma that has spread to the brain may cause headaches and sickness. These can be worse first thing in the morning. Other symptoms depend on the area of the brain affected. They may include numbness or weakness in a limb, or having a seizure (fit).

• #51 Signs and symptoms of advanced melanoma | Macmillan Cancer Support

  https://www.macmillan.org.uk/cancer-information-and-support/melanoma/advanced-melanoma/signs-and-symptoms-of-advanced-melanoma

  Advanced melanoma can cause different symptoms. This depends on where in the body melanoma has spread to. […] You may notice a lump and the lymph nodes may feel hard and swollen. Sometimes, they press on tissues or nerves nearby, causing pain. […] Melanoma that spreads to areas of skin far away from the original melanoma appears as firm or hard lumps called nodules. Or there may be flat, grey or purple areas of skin. These lumps or areas may bleed. […] If melanoma spreads to the lungs, it may cause symptoms such as breathlessness, a cough, and coughing up blood. […] Melanoma that has spread to the brain may cause headaches and sickness. These can be worse first thing in the morning. Other symptoms depend on the area of the brain affected. They may include numbness or weakness in a limb, or having a seizure (fit).

• #52 Symptoms of advanced melanoma skin cancer | Cancer Research UK

  https://www.cancerresearchuk.org/about-cancer/melanoma/advanced-melanoma/symptoms-advanced-melanoma

  Advanced melanoma skin cancer means it has spread to another part of the body such as the liver, lungs or bone. […] Some people may not get symptoms when they have advanced cancer. Their doctor may find the cancer has spread during a scan for a follow up appointment. If they do have symptoms, these will depend on where the cancer has spread to. […] The symptoms of advanced cancer depend on where the cancer is in your body. But general symptoms might include: hard or swollen lymph nodes, a hard lump on your skin, unexplained pain, feeling very tired or unwell, unexplained weight loss. […] If the cancer has spread to your lymph nodes they can feel hard or swollen. Swollen lymph nodes in the neck area can make it hard to swallow. […] You may have any of these symptoms if your cancer has spread into the lungs: a cough that doesn’t go away, breathlessness, ongoing chest infections, coughing up blood, a buildup of fluid between the chest wall and the lung (a pleural effusion).

• #53 Symptoms of advanced melanoma skin cancer | Cancer Research UK

  https://www.cancerresearchuk.org/about-cancer/melanoma/advanced-melanoma/symptoms-advanced-melanoma

  Advanced melanoma skin cancer means it has spread to another part of the body such as the liver, lungs or bone. […] Some people may not get symptoms when they have advanced cancer. Their doctor may find the cancer has spread during a scan for a follow up appointment. If they do have symptoms, these will depend on where the cancer has spread to. […] The symptoms of advanced cancer depend on where the cancer is in your body. But general symptoms might include: hard or swollen lymph nodes, a hard lump on your skin, unexplained pain, feeling very tired or unwell, unexplained weight loss. […] If the cancer has spread to your lymph nodes they can feel hard or swollen. Swollen lymph nodes in the neck area can make it hard to swallow. […] You may have any of these symptoms if your cancer has spread into the lungs: a cough that doesn’t go away, breathlessness, ongoing chest infections, coughing up blood, a buildup of fluid between the chest wall and the lung (a pleural effusion).

• #54 Metastatic Melanoma Stage 3 and 4 Symptoms, Survival Rate

  https://www.cancercenter.com/cancer-types/melanoma/types/metastatic-melanoma

  Melanoma usually is found in early stages, before its become metastatic. If you notice any abnormal moles or discolorations on your skin, dont hesitate to reach out to your doctor. This is especially important for those with many risk factors. Melanoma is more treatable at early stages, so early identification may prevent metastatic melanoma from developing. […] Metastatic melanoma symptoms and signs may include: Fatigue, Swollen or painful lymph nodes, Weight loss, Loss of appetite, Trouble breathing or a cough that doesnt go away, Bone pain, Headaches, Seizures, Swelling of the liver. […] Symptoms vary depending on where the metastasis spreads in the body. […] If melanoma spreads to the lungs, specific symptoms may include: Coughing, with or without blood, Chest pain, Shortness of breath, Fluid around the lungs.

• #55 Symptoms of advanced melanoma skin cancer | Cancer Research UK

  https://www.cancerresearchuk.org/about-cancer/melanoma/advanced-melanoma/symptoms-advanced-melanoma

  Advanced melanoma skin cancer means it has spread to another part of the body such as the liver, lungs or bone. […] Some people may not get symptoms when they have advanced cancer. Their doctor may find the cancer has spread during a scan for a follow up appointment. If they do have symptoms, these will depend on where the cancer has spread to. […] The symptoms of advanced cancer depend on where the cancer is in your body. But general symptoms might include: hard or swollen lymph nodes, a hard lump on your skin, unexplained pain, feeling very tired or unwell, unexplained weight loss. […] If the cancer has spread to your lymph nodes they can feel hard or swollen. Swollen lymph nodes in the neck area can make it hard to swallow. […] You may have any of these symptoms if your cancer has spread into the lungs: a cough that doesn’t go away, breathlessness, ongoing chest infections, coughing up blood, a buildup of fluid between the chest wall and the lung (a pleural effusion).

• #56 Symptoms of advanced melanoma skin cancer | Cancer Research UK

  https://www.cancerresearchuk.org/about-cancer/melanoma/advanced-melanoma/symptoms-advanced-melanoma

  Advanced melanoma skin cancer means it has spread to another part of the body such as the liver, lungs or bone. […] Some people may not get symptoms when they have advanced cancer. Their doctor may find the cancer has spread during a scan for a follow up appointment. If they do have symptoms, these will depend on where the cancer has spread to. […] The symptoms of advanced cancer depend on where the cancer is in your body. But general symptoms might include: hard or swollen lymph nodes, a hard lump on your skin, unexplained pain, feeling very tired or unwell, unexplained weight loss. […] If the cancer has spread to your lymph nodes they can feel hard or swollen. Swollen lymph nodes in the neck area can make it hard to swallow. […] You may have any of these symptoms if your cancer has spread into the lungs: a cough that doesn’t go away, breathlessness, ongoing chest infections, coughing up blood, a buildup of fluid between the chest wall and the lung (a pleural effusion).

• #57 Symptoms of advanced melanoma skin cancer | Cancer Research UK

  https://www.cancerresearchuk.org/about-cancer/melanoma/advanced-melanoma/symptoms-advanced-melanoma

  You might have any of the following symptoms if your cancer has spread to the liver: discomfort or pain on the right side of your tummy (abdomen), feeling sick, poor appetite and weight loss, a swollen tummy (called ascites), yellowing of the skin and whites of the eyes (jaundice), itchy skin. […] You might have any of the following symptoms if your cancer has spread to the bones: pain from breakdown of the bone the pain is continuous and people often describe it as gnawing, backache, which gets worse despite resting, weaker bones they can break more easily, raised blood calcium (hypercalcaemia), which can cause dehydration, confusion, sickness, tummy (abdominal) pain and constipation, low levels of blood cells blood cells are made in the bone marrow and can be crowded out by the cancer cells, causing anaemia, increased risk of infection, bruising and bleeding.

• #58 Symptoms of advanced melanoma skin cancer | Cancer Research UK

  https://www.cancerresearchuk.org/about-cancer/melanoma/advanced-melanoma/symptoms-advanced-melanoma

  You might have any of the following symptoms if your cancer has spread to the liver: discomfort or pain on the right side of your tummy (abdomen), feeling sick, poor appetite and weight loss, a swollen tummy (called ascites), yellowing of the skin and whites of the eyes (jaundice), itchy skin. […] You might have any of the following symptoms if your cancer has spread to the bones: pain from breakdown of the bone the pain is continuous and people often describe it as gnawing, backache, which gets worse despite resting, weaker bones they can break more easily, raised blood calcium (hypercalcaemia), which can cause dehydration, confusion, sickness, tummy (abdominal) pain and constipation, low levels of blood cells blood cells are made in the bone marrow and can be crowded out by the cancer cells, causing anaemia, increased risk of infection, bruising and bleeding.

• #59 Symptoms of advanced melanoma skin cancer | Cancer Research UK

  https://www.cancerresearchuk.org/about-cancer/melanoma/advanced-melanoma/symptoms-advanced-melanoma

  You might have any of the following symptoms if your cancer has spread to the liver: discomfort or pain on the right side of your tummy (abdomen), feeling sick, poor appetite and weight loss, a swollen tummy (called ascites), yellowing of the skin and whites of the eyes (jaundice), itchy skin. […] You might have any of the following symptoms if your cancer has spread to the bones: pain from breakdown of the bone the pain is continuous and people often describe it as gnawing, backache, which gets worse despite resting, weaker bones they can break more easily, raised blood calcium (hypercalcaemia), which can cause dehydration, confusion, sickness, tummy (abdominal) pain and constipation, low levels of blood cells blood cells are made in the bone marrow and can be crowded out by the cancer cells, causing anaemia, increased risk of infection, bruising and bleeding.

• #60 Symptoms of advanced melanoma skin cancer | Cancer Research UK

  https://www.cancerresearchuk.org/about-cancer/melanoma/advanced-melanoma/symptoms-advanced-melanoma

  You might have any of the following symptoms if your cancer has spread to the liver: discomfort or pain on the right side of your tummy (abdomen), feeling sick, poor appetite and weight loss, a swollen tummy (called ascites), yellowing of the skin and whites of the eyes (jaundice), itchy skin. […] You might have any of the following symptoms if your cancer has spread to the bones: pain from breakdown of the bone the pain is continuous and people often describe it as gnawing, backache, which gets worse despite resting, weaker bones they can break more easily, raised blood calcium (hypercalcaemia), which can cause dehydration, confusion, sickness, tummy (abdominal) pain and constipation, low levels of blood cells blood cells are made in the bone marrow and can be crowded out by the cancer cells, causing anaemia, increased risk of infection, bruising and bleeding.

• #61 Symptoms of advanced melanoma skin cancer | Cancer Research UK

  https://www.cancerresearchuk.org/about-cancer/melanoma/advanced-melanoma/symptoms-advanced-melanoma

  You might have any of the following symptoms if your cancer has spread to the liver: discomfort or pain on the right side of your tummy (abdomen), feeling sick, poor appetite and weight loss, a swollen tummy (called ascites), yellowing of the skin and whites of the eyes (jaundice), itchy skin. […] You might have any of the following symptoms if your cancer has spread to the bones: pain from breakdown of the bone the pain is continuous and people often describe it as gnawing, backache, which gets worse despite resting, weaker bones they can break more easily, raised blood calcium (hypercalcaemia), which can cause dehydration, confusion, sickness, tummy (abdominal) pain and constipation, low levels of blood cells blood cells are made in the bone marrow and can be crowded out by the cancer cells, causing anaemia, increased risk of infection, bruising and bleeding.

• #62 Symptoms of advanced melanoma skin cancer | Cancer Research UK

  https://www.cancerresearchuk.org/about-cancer/melanoma/advanced-melanoma/symptoms-advanced-melanoma

  You might have any of the following symptoms if your cancer has spread to the liver: discomfort or pain on the right side of your tummy (abdomen), feeling sick, poor appetite and weight loss, a swollen tummy (called ascites), yellowing of the skin and whites of the eyes (jaundice), itchy skin. […] You might have any of the following symptoms if your cancer has spread to the bones: pain from breakdown of the bone the pain is continuous and people often describe it as gnawing, backache, which gets worse despite resting, weaker bones they can break more easily, raised blood calcium (hypercalcaemia), which can cause dehydration, confusion, sickness, tummy (abdominal) pain and constipation, low levels of blood cells blood cells are made in the bone marrow and can be crowded out by the cancer cells, causing anaemia, increased risk of infection, bruising and bleeding.

• #63 Symptoms of advanced melanoma skin cancer | Cancer Research UK

  https://www.cancerresearchuk.org/about-cancer/melanoma/advanced-melanoma/symptoms-advanced-melanoma

  You might have any of the following symptoms if your cancer has spread to the liver: discomfort or pain on the right side of your tummy (abdomen), feeling sick, poor appetite and weight loss, a swollen tummy (called ascites), yellowing of the skin and whites of the eyes (jaundice), itchy skin. […] You might have any of the following symptoms if your cancer has spread to the bones: pain from breakdown of the bone the pain is continuous and people often describe it as gnawing, backache, which gets worse despite resting, weaker bones they can break more easily, raised blood calcium (hypercalcaemia), which can cause dehydration, confusion, sickness, tummy (abdominal) pain and constipation, low levels of blood cells blood cells are made in the bone marrow and can be crowded out by the cancer cells, causing anaemia, increased risk of infection, bruising and bleeding.

• #64 Symptoms of advanced melanoma skin cancer | Cancer Research UK

  https://www.cancerresearchuk.org/about-cancer/melanoma/advanced-melanoma/symptoms-advanced-melanoma

  You might have any of the following symptoms if your cancer has spread to the liver: discomfort or pain on the right side of your tummy (abdomen), feeling sick, poor appetite and weight loss, a swollen tummy (called ascites), yellowing of the skin and whites of the eyes (jaundice), itchy skin. […] You might have any of the following symptoms if your cancer has spread to the bones: pain from breakdown of the bone the pain is continuous and people often describe it as gnawing, backache, which gets worse despite resting, weaker bones they can break more easily, raised blood calcium (hypercalcaemia), which can cause dehydration, confusion, sickness, tummy (abdominal) pain and constipation, low levels of blood cells blood cells are made in the bone marrow and can be crowded out by the cancer cells, causing anaemia, increased risk of infection, bruising and bleeding.

• #65 Symptoms of advanced melanoma skin cancer | Cancer Research UK

  https://www.cancerresearchuk.org/about-cancer/melanoma/advanced-melanoma/symptoms-advanced-melanoma

  You might have any of the following symptoms if your cancer has spread to the liver: discomfort or pain on the right side of your tummy (abdomen), feeling sick, poor appetite and weight loss, a swollen tummy (called ascites), yellowing of the skin and whites of the eyes (jaundice), itchy skin. […] You might have any of the following symptoms if your cancer has spread to the bones: pain from breakdown of the bone the pain is continuous and people often describe it as gnawing, backache, which gets worse despite resting, weaker bones they can break more easily, raised blood calcium (hypercalcaemia), which can cause dehydration, confusion, sickness, tummy (abdominal) pain and constipation, low levels of blood cells blood cells are made in the bone marrow and can be crowded out by the cancer cells, causing anaemia, increased risk of infection, bruising and bleeding.

• #66 Symptoms of advanced melanoma skin cancer | Cancer Research UK

  https://www.cancerresearchuk.org/about-cancer/melanoma/advanced-melanoma/symptoms-advanced-melanoma

  You might have any of the following symptoms if your cancer has spread to the liver: discomfort or pain on the right side of your tummy (abdomen), feeling sick, poor appetite and weight loss, a swollen tummy (called ascites), yellowing of the skin and whites of the eyes (jaundice), itchy skin. […] You might have any of the following symptoms if your cancer has spread to the bones: pain from breakdown of the bone the pain is continuous and people often describe it as gnawing, backache, which gets worse despite resting, weaker bones they can break more easily, raised blood calcium (hypercalcaemia), which can cause dehydration, confusion, sickness, tummy (abdominal) pain and constipation, low levels of blood cells blood cells are made in the bone marrow and can be crowded out by the cancer cells, causing anaemia, increased risk of infection, bruising and bleeding.

• #67 Symptoms of advanced melanoma skin cancer | Cancer Research UK

  https://www.cancerresearchuk.org/about-cancer/melanoma/advanced-melanoma/symptoms-advanced-melanoma

  You might have any of the following symptoms if your cancer has spread to the liver: discomfort or pain on the right side of your tummy (abdomen), feeling sick, poor appetite and weight loss, a swollen tummy (called ascites), yellowing of the skin and whites of the eyes (jaundice), itchy skin. […] You might have any of the following symptoms if your cancer has spread to the bones: pain from breakdown of the bone the pain is continuous and people often describe it as gnawing, backache, which gets worse despite resting, weaker bones they can break more easily, raised blood calcium (hypercalcaemia), which can cause dehydration, confusion, sickness, tummy (abdominal) pain and constipation, low levels of blood cells blood cells are made in the bone marrow and can be crowded out by the cancer cells, causing anaemia, increased risk of infection, bruising and bleeding.

• #68 Symptoms of advanced melanoma skin cancer | Cancer Research UK

  https://www.cancerresearchuk.org/about-cancer/melanoma/advanced-melanoma/symptoms-advanced-melanoma

  You might have any of the following symptoms if the cancer has spread to your brain: memory problems, mood or personality changes, seizures, confusion, severe headaches, often with sickness, weakness of an arm or leg. […] Most people don’t have any symptoms if the melanoma has spread to the small bowel. But if you do they might include: pain in the abdomen, indigestion, feeling or being sick, weight loss, anaemia. […] The secondary cancer may also press on the small bowel and block or partially block it. This is called bowel obstruction. Bowel obstruction can cause cramping abdominal pain that comes in waves. You can also be sick, feel bloated and be unable to pass wind or have a poo.

• #69 Symptoms of advanced melanoma skin cancer | Cancer Research UK

  https://www.cancerresearchuk.org/about-cancer/melanoma/advanced-melanoma/symptoms-advanced-melanoma

  You might have any of the following symptoms if the cancer has spread to your brain: memory problems, mood or personality changes, seizures, confusion, severe headaches, often with sickness, weakness of an arm or leg. […] Most people don’t have any symptoms if the melanoma has spread to the small bowel. But if you do they might include: pain in the abdomen, indigestion, feeling or being sick, weight loss, anaemia. […] The secondary cancer may also press on the small bowel and block or partially block it. This is called bowel obstruction. Bowel obstruction can cause cramping abdominal pain that comes in waves. You can also be sick, feel bloated and be unable to pass wind or have a poo.

• #70 Symptoms of advanced melanoma skin cancer | Cancer Research UK

  https://www.cancerresearchuk.org/about-cancer/melanoma/advanced-melanoma/symptoms-advanced-melanoma

  You might have any of the following symptoms if the cancer has spread to your brain: memory problems, mood or personality changes, seizures, confusion, severe headaches, often with sickness, weakness of an arm or leg. […] Most people don’t have any symptoms if the melanoma has spread to the small bowel. But if you do they might include: pain in the abdomen, indigestion, feeling or being sick, weight loss, anaemia. […] The secondary cancer may also press on the small bowel and block or partially block it. This is called bowel obstruction. Bowel obstruction can cause cramping abdominal pain that comes in waves. You can also be sick, feel bloated and be unable to pass wind or have a poo.

• #71 Metastatic Melanoma Stage 3 and 4 Symptoms, Survival Rate

  https://www.cancercenter.com/cancer-types/melanoma/types/metastatic-melanoma

  Melanoma usually is found in early stages, before its become metastatic. If you notice any abnormal moles or discolorations on your skin, dont hesitate to reach out to your doctor. This is especially important for those with many risk factors. Melanoma is more treatable at early stages, so early identification may prevent metastatic melanoma from developing. […] Metastatic melanoma symptoms and signs may include: Fatigue, Swollen or painful lymph nodes, Weight loss, Loss of appetite, Trouble breathing or a cough that doesnt go away, Bone pain, Headaches, Seizures, Swelling of the liver. […] Symptoms vary depending on where the metastasis spreads in the body. […] If melanoma spreads to the lungs, specific symptoms may include: Coughing, with or without blood, Chest pain, Shortness of breath, Fluid around the lungs.

• #72 Symptoms of advanced melanoma skin cancer | Cancer Research UK

  https://www.cancerresearchuk.org/about-cancer/melanoma/advanced-melanoma/symptoms-advanced-melanoma

  You might have any of the following symptoms if the cancer has spread to your brain: memory problems, mood or personality changes, seizures, confusion, severe headaches, often with sickness, weakness of an arm or leg. […] Most people don’t have any symptoms if the melanoma has spread to the small bowel. But if you do they might include: pain in the abdomen, indigestion, feeling or being sick, weight loss, anaemia. […] The secondary cancer may also press on the small bowel and block or partially block it. This is called bowel obstruction. Bowel obstruction can cause cramping abdominal pain that comes in waves. You can also be sick, feel bloated and be unable to pass wind or have a poo.

• #73 Symptoms of advanced melanoma skin cancer | Cancer Research UK

  https://www.cancerresearchuk.org/about-cancer/melanoma/advanced-melanoma/symptoms-advanced-melanoma

  You might have any of the following symptoms if the cancer has spread to your brain: memory problems, mood or personality changes, seizures, confusion, severe headaches, often with sickness, weakness of an arm or leg. […] Most people don’t have any symptoms if the melanoma has spread to the small bowel. But if you do they might include: pain in the abdomen, indigestion, feeling or being sick, weight loss, anaemia. […] The secondary cancer may also press on the small bowel and block or partially block it. This is called bowel obstruction. Bowel obstruction can cause cramping abdominal pain that comes in waves. You can also be sick, feel bloated and be unable to pass wind or have a poo.

• #74 Symptoms of advanced melanoma skin cancer | Cancer Research UK

  https://www.cancerresearchuk.org/about-cancer/melanoma/advanced-melanoma/symptoms-advanced-melanoma

  You might have any of the following symptoms if the cancer has spread to your brain: memory problems, mood or personality changes, seizures, confusion, severe headaches, often with sickness, weakness of an arm or leg. […] Most people don’t have any symptoms if the melanoma has spread to the small bowel. But if you do they might include: pain in the abdomen, indigestion, feeling or being sick, weight loss, anaemia. […] The secondary cancer may also press on the small bowel and block or partially block it. This is called bowel obstruction. Bowel obstruction can cause cramping abdominal pain that comes in waves. You can also be sick, feel bloated and be unable to pass wind or have a poo.

• #75 Symptoms of advanced melanoma skin cancer | Cancer Research UK

  https://www.cancerresearchuk.org/about-cancer/melanoma/advanced-melanoma/symptoms-advanced-melanoma

  You might have any of the following symptoms if the cancer has spread to your brain: memory problems, mood or personality changes, seizures, confusion, severe headaches, often with sickness, weakness of an arm or leg. […] Most people don’t have any symptoms if the melanoma has spread to the small bowel. But if you do they might include: pain in the abdomen, indigestion, feeling or being sick, weight loss, anaemia. […] The secondary cancer may also press on the small bowel and block or partially block it. This is called bowel obstruction. Bowel obstruction can cause cramping abdominal pain that comes in waves. You can also be sick, feel bloated and be unable to pass wind or have a poo.

• #76 Symptoms of advanced melanoma skin cancer | Cancer Research UK

  https://www.cancerresearchuk.org/about-cancer/melanoma/advanced-melanoma/symptoms-advanced-melanoma

  You might have any of the following symptoms if the cancer has spread to your brain: memory problems, mood or personality changes, seizures, confusion, severe headaches, often with sickness, weakness of an arm or leg. […] Most people don’t have any symptoms if the melanoma has spread to the small bowel. But if you do they might include: pain in the abdomen, indigestion, feeling or being sick, weight loss, anaemia. […] The secondary cancer may also press on the small bowel and block or partially block it. This is called bowel obstruction. Bowel obstruction can cause cramping abdominal pain that comes in waves. You can also be sick, feel bloated and be unable to pass wind or have a poo.

• #77 Symptoms of advanced melanoma skin cancer | Cancer Research UK

  https://www.cancerresearchuk.org/about-cancer/melanoma/advanced-melanoma/symptoms-advanced-melanoma

  You might have any of the following symptoms if the cancer has spread to your brain: memory problems, mood or personality changes, seizures, confusion, severe headaches, often with sickness, weakness of an arm or leg. […] Most people don’t have any symptoms if the melanoma has spread to the small bowel. But if you do they might include: pain in the abdomen, indigestion, feeling or being sick, weight loss, anaemia. […] The secondary cancer may also press on the small bowel and block or partially block it. This is called bowel obstruction. Bowel obstruction can cause cramping abdominal pain that comes in waves. You can also be sick, feel bloated and be unable to pass wind or have a poo.

• #78 Symptoms of advanced melanoma skin cancer | Cancer Research UK

  https://www.cancerresearchuk.org/about-cancer/melanoma/advanced-melanoma/symptoms-advanced-melanoma

  You might have any of the following symptoms if the cancer has spread to your brain: memory problems, mood or personality changes, seizures, confusion, severe headaches, often with sickness, weakness of an arm or leg. […] Most people don’t have any symptoms if the melanoma has spread to the small bowel. But if you do they might include: pain in the abdomen, indigestion, feeling or being sick, weight loss, anaemia. […] The secondary cancer may also press on the small bowel and block or partially block it. This is called bowel obstruction. Bowel obstruction can cause cramping abdominal pain that comes in waves. You can also be sick, feel bloated and be unable to pass wind or have a poo.

• #79 Symptoms of advanced melanoma skin cancer | Cancer Research UK

  https://www.cancerresearchuk.org/about-cancer/melanoma/advanced-melanoma/symptoms-advanced-melanoma

  You might have any of the following symptoms if the cancer has spread to your brain: memory problems, mood or personality changes, seizures, confusion, severe headaches, often with sickness, weakness of an arm or leg. […] Most people don’t have any symptoms if the melanoma has spread to the small bowel. But if you do they might include: pain in the abdomen, indigestion, feeling or being sick, weight loss, anaemia. […] The secondary cancer may also press on the small bowel and block or partially block it. This is called bowel obstruction. Bowel obstruction can cause cramping abdominal pain that comes in waves. You can also be sick, feel bloated and be unable to pass wind or have a poo.

• #80 Symptoms of advanced melanoma skin cancer | Cancer Research UK

  https://www.cancerresearchuk.org/about-cancer/melanoma/advanced-melanoma/symptoms-advanced-melanoma

  You might have any of the following symptoms if the cancer has spread to your brain: memory problems, mood or personality changes, seizures, confusion, severe headaches, often with sickness, weakness of an arm or leg. […] Most people don’t have any symptoms if the melanoma has spread to the small bowel. But if you do they might include: pain in the abdomen, indigestion, feeling or being sick, weight loss, anaemia. […] The secondary cancer may also press on the small bowel and block or partially block it. This is called bowel obstruction. Bowel obstruction can cause cramping abdominal pain that comes in waves. You can also be sick, feel bloated and be unable to pass wind or have a poo.

• #81 Metastatic Melanoma Stage 3 and 4 Symptoms, Survival Rate

  https://www.cancercenter.com/cancer-types/melanoma/types/metastatic-melanoma

  Melanoma usually is found in early stages, before its become metastatic. If you notice any abnormal moles or discolorations on your skin, dont hesitate to reach out to your doctor. This is especially important for those with many risk factors. Melanoma is more treatable at early stages, so early identification may prevent metastatic melanoma from developing. […] Metastatic melanoma symptoms and signs may include: Fatigue, Swollen or painful lymph nodes, Weight loss, Loss of appetite, Trouble breathing or a cough that doesnt go away, Bone pain, Headaches, Seizures, Swelling of the liver. […] Symptoms vary depending on where the metastasis spreads in the body. […] If melanoma spreads to the lungs, specific symptoms may include: Coughing, with or without blood, Chest pain, Shortness of breath, Fluid around the lungs.

• #82 Metastatic Melanoma Stage 3 and 4 Symptoms, Survival Rate

  https://www.cancercenter.com/cancer-types/melanoma/types/metastatic-melanoma

  Melanoma usually is found in early stages, before its become metastatic. If you notice any abnormal moles or discolorations on your skin, dont hesitate to reach out to your doctor. This is especially important for those with many risk factors. Melanoma is more treatable at early stages, so early identification may prevent metastatic melanoma from developing. […] Metastatic melanoma symptoms and signs may include: Fatigue, Swollen or painful lymph nodes, Weight loss, Loss of appetite, Trouble breathing or a cough that doesnt go away, Bone pain, Headaches, Seizures, Swelling of the liver. […] Symptoms vary depending on where the metastasis spreads in the body. […] If melanoma spreads to the lungs, specific symptoms may include: Coughing, with or without blood, Chest pain, Shortness of breath, Fluid around the lungs.

• #83 Metastatic Melanoma Stage 3 and 4 Symptoms, Survival Rate

  https://www.cancercenter.com/cancer-types/melanoma/types/metastatic-melanoma

  Melanoma usually is found in early stages, before its become metastatic. If you notice any abnormal moles or discolorations on your skin, dont hesitate to reach out to your doctor. This is especially important for those with many risk factors. Melanoma is more treatable at early stages, so early identification may prevent metastatic melanoma from developing. […] Metastatic melanoma symptoms and signs may include: Fatigue, Swollen or painful lymph nodes, Weight loss, Loss of appetite, Trouble breathing or a cough that doesnt go away, Bone pain, Headaches, Seizures, Swelling of the liver. […] Symptoms vary depending on where the metastasis spreads in the body. […] If melanoma spreads to the lungs, specific symptoms may include: Coughing, with or without blood, Chest pain, Shortness of breath, Fluid around the lungs.

• #84 7 Signs Your Melanoma Has Spread – Massive Bio

  https://massivebio.com/7-signs-your-melanoma-has-spread/

  As melanoma progresses, more specific symptoms may emerge, indicating a more advanced stage or the development of metastatic melanoma. These can include unexpected weight loss, persistent fatigue, and the appearance of new, unusual growths on the skin. […] In stage III melanoma, cancer spreads to lymph nodes near the original tumor. In stage IV melanoma, the disease can migrate to lymph nodes far from the tumor. […] Pain and tenderness in the mid-section could be a sign that melanoma has spread to the liver. […] The brain is another common site for melanoma metastasis. […] When melanoma or any other cancer travels to the lungs, patients may feel chronic chest pain that cant be explained by other causes. […] However, unexplained weight loss and loss of appetite are also common symptoms of metastasis to the lungs. […] When melanoma metastasizes to the bone, it can cause severe and hard-to-treat pain, which is sometimes accompanied by fever. […] In some patients, spreading melanoma can produce nonspecific flu-like symptoms, such as fever and chills.

• #85 Melanoma – Wikipedia

  https://en.wikipedia.org/wiki/Melanoma

  The likelihood that melanoma will reoccur or spread depends on its thickness, how fast the cells are dividing, and whether or not the overlying skin has broken down. […] Stage IV melanoma, in which it has metastasized, is the most deadly skin malignancy: five-year survival is 22.5%. When there is distant metastasis, the cancer is generally considered incurable. The five-year survival rate is less than 10%. The median survival is 6–12 months. Treatment is palliative, focusing on life extension and quality of life. In some cases, patients may live many months or even years with metastatic melanoma (depending on the aggressiveness of the treatment). Metastases to skin and lungs have a better prognosis. Metastases to brain, bone and liver are associated with a worse prognosis. Survival is better with metastasis in which the location of the primary tumor is unknown.

• #86 Melanoma Skin Cancer: Images, Diagnosis, and Treatment — DermNet

  https://dermnetnz.org/topics/melanoma

  The risk of spread and ultimate death from invasive melanoma depends on several factors, including anatomic location, pathologic factors, and mutation status. However, the main factor is the Breslow thickness of the melanoma at the time it was surgically removed. […] Metastases are rare for melanomas < 0.75 mm in size, and the risk associated with tumours 0.75–1 mm thick is about 5%. The risk steadily increases with thickness so that melanomas > 4 mm have a risk of metastasis of about 40%.

• #87 Melanoma Pictures, Causes, Stages, Symptoms & Survival Rate

  https://www.medicinenet.com/melanoma/article.htm

  Signs and symptoms depend upon the site of metastasis and the number of tumors there. Metastases to the brain may first appear as headaches, unusual numbness in the arms and legs, or seizures. […] A very high tumor burden may lead to fatigue, weight loss, weakness, and, in rare cases, the release of so much melanin into the circulation that the patient may develop brown or black urine and have their skin turn a diffuse slate-gray color. […] The most useful criterion for determining prognosis is tumor thickness. Tumor thickness is measured in fractions of millimeters and is called Breslow’s depth. The thinner the melanoma, the better the prognosis. […] Melanoma is staged according to thickness, ulceration, lymph node involvement, and the presence of distant metastasis. […] In general, early localized melanoma is treated by surgery alone.

• #88 Stage 4 Melanoma: Symptoms and Pictures

  https://www.verywellhealth.com/stage-4-melanoma-5101631

  Stage 4 melanoma, otherwise known as metastatic melanoma, is the most advanced form of melanoma, a serious form of skin cancer that begins in cells known as melanocytes. In stage 4, the melanoma has spread to other parts of the body or distant points in the skin. Symptoms vary from person to person, but the most common sign of melanoma is a new or changed mole. Any skin area that appears off in color, shape, size, or texture could also indicate melanoma. Typically, the ABCDE rule is used to identify changes in symmetry, shape, color, and size of the skin lesion. Melanoma tends to be asymmetrical. This means that the two sides of a melanoma will not be the same size or shape. The border or edge of the melanoma is irregular. Instead of a smooth circle or oval like many moles and freckles, the border of a melanoma is often jagged or poorly defined. Melanoma tends to be darker and is most frequently black, brown, and tan. The color is uneven. Other colors are possible; some melanomas are red, gray, white, pink, or blue. Most melanomas are 6 millimeters (about 0.75 of an inch) or bigger and may continue growing. Melanomas typically change in size, shape, and color over time. There may be other symptoms, too. For example, you may experience a change in sensation in a melanoma mole. It may itch or become painful. Metastatic melanoma most often spreads to the lymph nodes, brain, bones, liver, or lungs, and the additional symptoms experienced at this stage depend on where the melanoma has spread: A persistent cough or shortness of breath, headaches or seizures, swelling of the lymph nodes, loss of appetite or unexplained weight loss, bone pain or unusual fractures, nodules or masses in the skin away from the initial melanoma. A person with advanced melanoma may also experience some of the general symptoms of cancer, including hard or swollen lumps, fatigue, weight loss or gain, jaundice, new pain that doesn’t go away, fevers, headaches, cough or hoarseness that lasts, changes in bowel or bladder habits, night sweats, vision or hearing problems, sores or changes in the mouth. Changes in the skin occur throughout all stages of melanoma. The primary tumor may or may not show ulceration at any stage. However, when ulceration is present, the prognosis may be poorer. The thicker the tumor, the greater the chance it will spread. Melanomas with a tumor thickness of less than 1 millimeter generally don’t spread. If the cancer has reached stage 4, it typically presents with a tumor of any thickness that may or may not be ulcerated (any T), with or without spread to the nearby lymph nodes (any N), and with definite spread to distant lymph nodes or organs (M1). Melanoma can recur because screening tests may not catch every cancer cell within the body, and the leftover cells could grow into another tumor. Melanoma has a recurrence rate of around 13.4% in individuals with a previous case of the disease. This recurrence rate is 70.2% within two years of initial diagnosis for people in stages 1 through 3 and 29.8% for those in stage 4.

• #89 Melanoma – Wikipedia

  https://en.wikipedia.org/wiki/Melanoma

  The likelihood that melanoma will reoccur or spread depends on its thickness, how fast the cells are dividing, and whether or not the overlying skin has broken down. […] Stage IV melanoma, in which it has metastasized, is the most deadly skin malignancy: five-year survival is 22.5%. When there is distant metastasis, the cancer is generally considered incurable. The five-year survival rate is less than 10%. The median survival is 6–12 months. Treatment is palliative, focusing on life extension and quality of life. In some cases, patients may live many months or even years with metastatic melanoma (depending on the aggressiveness of the treatment). Metastases to skin and lungs have a better prognosis. Metastases to brain, bone and liver are associated with a worse prognosis. Survival is better with metastasis in which the location of the primary tumor is unknown.

• #90 Melanoma – Wikipedia

  https://en.wikipedia.org/wiki/Melanoma

  The likelihood that melanoma will reoccur or spread depends on its thickness, how fast the cells are dividing, and whether or not the overlying skin has broken down. […] Stage IV melanoma, in which it has metastasized, is the most deadly skin malignancy: five-year survival is 22.5%. When there is distant metastasis, the cancer is generally considered incurable. The five-year survival rate is less than 10%. The median survival is 6–12 months. Treatment is palliative, focusing on life extension and quality of life. In some cases, patients may live many months or even years with metastatic melanoma (depending on the aggressiveness of the treatment). Metastases to skin and lungs have a better prognosis. Metastases to brain, bone and liver are associated with a worse prognosis. Survival is better with metastasis in which the location of the primary tumor is unknown.

• #91 Metastatic Melanoma Stage 3 and 4 Symptoms, Survival Rate

  https://www.cancercenter.com/cancer-types/melanoma/types/metastatic-melanoma

  Stages 0, 1 and 2 are melanoma. Stage 3 (some cases) and stage 4 melanomas are considered metastatic melanomas. […] Once a melanoma has spread to distant parts of the body, such as the lungs, liver or other areas of skin, its considered stage 4. This cancer can be any thickness and may or may not have spread to nearby lymph nodes. […] The five-year survival rate for people diagnosed with melanoma that has spread to nearby lymph nodes is 66 percent, according to the American Cancer Society. When cancer has spread to distant parts of the body, there may also be other metastases too small to detect by scans. For people diagnosed with stage 4 melanoma, or melanoma that has spread to distant parts of the body, the five-year survival rate is 27 percent. […] According to the American Cancer Society, the five-year survival rate for people diagnosed with stage 3 melanoma that has spread to nearby lymph nodes or structures (regional spread) is 66 percent. For patients diagnosed with stage 4 melanoma (distant spread), the five-year survival rate is 27 percent. […] Stage 4 melanoma has a high likelihood of recurring and is considered difficult to treat.

• #92 Melanoma – Wikipedia

  https://en.wikipedia.org/wiki/Melanoma

  The likelihood that melanoma will reoccur or spread depends on its thickness, how fast the cells are dividing, and whether or not the overlying skin has broken down. […] Stage IV melanoma, in which it has metastasized, is the most deadly skin malignancy: five-year survival is 22.5%. When there is distant metastasis, the cancer is generally considered incurable. The five-year survival rate is less than 10%. The median survival is 6–12 months. Treatment is palliative, focusing on life extension and quality of life. In some cases, patients may live many months or even years with metastatic melanoma (depending on the aggressiveness of the treatment). Metastases to skin and lungs have a better prognosis. Metastases to brain, bone and liver are associated with a worse prognosis. Survival is better with metastasis in which the location of the primary tumor is unknown.

• #93 Stages of Melanoma – AIM at Melanoma Foundation

  https://www.aimatmelanoma.org/stages-of-melanoma/

  Stage III melanoma is defined by the level of lymph node involvement and ulceration. In Stage III melanoma, the cancer has spread to one or more regional lymph nodes or has developed a deposit of melanoma in the skin or dermis along the lymphatics prior to reaching a lymph node called an in transit or satellite metastasis. There is no evidence the cancer has spread to distant sites (metastasis). […] In Stage IV melanoma, the cancer has spread beyond the original tumor site and regional lymph nodes to more distant areas of the body. The most common sites of metastasis are distant skin and lymph nodes, then lungs, liver, brain, bone, and/or intestines. The level of serum lactate dehydrogenase (LDH) may or may not be elevated. […] Brain metastases, a specific form of Stage IV melanoma, are one of the most common and difficult-to-treat complications of melanoma. They differ from all other metastases in terms of risk factors, diagnosis, and treatment.

• #94 Decoding Melanoma Development and Progression: Identification of Therapeutic Vulnerabilities

  https://pmc.ncbi.nlm.nih.gov/articles/PMC7891057/

  Melanoma, a cancer of the skin, arises from transformed melanocytes. Melanoma has the highest mutational burden of any cancer partially attributed to UV induced DNA damage. Diagnosing melanoma in its early stages, in situ, is crucial for the prognosis and survival of this deadly disease as the 5-year survival rate for primary melanoma is 99% and for metastatic melanoma is only 27%. Melanoma patients can be classified into five distinct stages, 0, I, II, III, and IV, as the stage increases the prognosis is worse. Stage 0 is defined as melanoma in situ while stage IV melanoma is known as metastatic melanoma. Metastatic melanoma is defined by the dissemination of primary melanoma cells to distant organs including but not limited to the lymph nodes, lungs, liver, brain, and bone. Great advances have been made in the understanding of melanoma pathogenesis that have resulted in improved disease treatment outcomes including targeted therapies: BRAF and MEK inhibitors and immunotherapies: monoclonal antibodies that target CTLA-4, PD-1 and PD-L1, however not all patients respond, and resistance eventually develops to these agents. This underscores the importance of dissecting the molecular pathways mediating metastasis, the processes of transitioning of an immobile melanoma cell into a motile cell that can successfully colonize distant organs. Melanoma has the highest mutational burden of any cancer as a result of UV induced DNA damage and/or DNA replication errors. After the accumulation of various mutations such as: CDKN2A, TP53, PTEN, and genes encoding SWI/SWF chromatin remodeling complex subunits, primary melanoma enters the invasive phase and becomes malignant melanoma. In addition to the genetic defects associated with metastatic melanoma development there are several dysregulated key signaling pathways that occur during melanoma progression such as the WNT, MAPK, and PI3K/AKT pathways. These pathways are involved in melanoma cell proliferation, growth, survival, evading cell death, and acquiring metastatic properties. During melanoma progression, elevated matrix metallopeptidase (MMP) expression and function have been detected. MMP facilitates the degradation of the ECM that supports melanoma growth during early stages and eventual migration to distant organs. Loss of the ECM enables melanoma cells to become anchorage independent and anoikis resistance that support melanoma dissemination through the circulatory system. In addition to modulations in the expression of cadherins during metastasis, integrins can be modulated to support motility and migration into hospitable metastatic niches by modifying basement membrane interactions, supporting angiogenesis formation and expression of MMPs. Melanoma cells must first dissociate from the primary tumor and undergo Epithelial Mesenchymal Transition (EMT), a process by which epithelial cells undergo morphological and phenotypic changes that allow them to become more migratory and invasive through tissues and enter circulation. Once in circulation, these traveling melanoma cells will migrate to their preferential metastatic organs mediated by chemotaxis of specific chemokine ligand-receptor interactions or by passive migration. If the environment of the metastatic niche is favorable, melanoma cells can successfully colonize there and become clinical detectable tumors.

• #95 Decoding Melanoma Development and Progression: Identification of Therapeutic Vulnerabilities

  https://pmc.ncbi.nlm.nih.gov/articles/PMC7891057/

  Melanoma, a cancer of the skin, arises from transformed melanocytes. Melanoma has the highest mutational burden of any cancer partially attributed to UV induced DNA damage. Diagnosing melanoma in its early stages, in situ, is crucial for the prognosis and survival of this deadly disease as the 5-year survival rate for primary melanoma is 99% and for metastatic melanoma is only 27%. Melanoma patients can be classified into five distinct stages, 0, I, II, III, and IV, as the stage increases the prognosis is worse. Stage 0 is defined as melanoma in situ while stage IV melanoma is known as metastatic melanoma. Metastatic melanoma is defined by the dissemination of primary melanoma cells to distant organs including but not limited to the lymph nodes, lungs, liver, brain, and bone. Great advances have been made in the understanding of melanoma pathogenesis that have resulted in improved disease treatment outcomes including targeted therapies: BRAF and MEK inhibitors and immunotherapies: monoclonal antibodies that target CTLA-4, PD-1 and PD-L1, however not all patients respond, and resistance eventually develops to these agents. This underscores the importance of dissecting the molecular pathways mediating metastasis, the processes of transitioning of an immobile melanoma cell into a motile cell that can successfully colonize distant organs. Melanoma has the highest mutational burden of any cancer as a result of UV induced DNA damage and/or DNA replication errors. After the accumulation of various mutations such as: CDKN2A, TP53, PTEN, and genes encoding SWI/SWF chromatin remodeling complex subunits, primary melanoma enters the invasive phase and becomes malignant melanoma. In addition to the genetic defects associated with metastatic melanoma development there are several dysregulated key signaling pathways that occur during melanoma progression such as the WNT, MAPK, and PI3K/AKT pathways. These pathways are involved in melanoma cell proliferation, growth, survival, evading cell death, and acquiring metastatic properties. During melanoma progression, elevated matrix metallopeptidase (MMP) expression and function have been detected. MMP facilitates the degradation of the ECM that supports melanoma growth during early stages and eventual migration to distant organs. Loss of the ECM enables melanoma cells to become anchorage independent and anoikis resistance that support melanoma dissemination through the circulatory system. In addition to modulations in the expression of cadherins during metastasis, integrins can be modulated to support motility and migration into hospitable metastatic niches by modifying basement membrane interactions, supporting angiogenesis formation and expression of MMPs. Melanoma cells must first dissociate from the primary tumor and undergo Epithelial Mesenchymal Transition (EMT), a process by which epithelial cells undergo morphological and phenotypic changes that allow them to become more migratory and invasive through tissues and enter circulation. Once in circulation, these traveling melanoma cells will migrate to their preferential metastatic organs mediated by chemotaxis of specific chemokine ligand-receptor interactions or by passive migration. If the environment of the metastatic niche is favorable, melanoma cells can successfully colonize there and become clinical detectable tumors.

• #96 Decoding Melanoma Development and Progression: Identification of Therapeutic Vulnerabilities

  https://pmc.ncbi.nlm.nih.gov/articles/PMC7891057/

  Melanoma, a cancer of the skin, arises from transformed melanocytes. Melanoma has the highest mutational burden of any cancer partially attributed to UV induced DNA damage. Diagnosing melanoma in its early stages, in situ, is crucial for the prognosis and survival of this deadly disease as the 5-year survival rate for primary melanoma is 99% and for metastatic melanoma is only 27%. Melanoma patients can be classified into five distinct stages, 0, I, II, III, and IV, as the stage increases the prognosis is worse. Stage 0 is defined as melanoma in situ while stage IV melanoma is known as metastatic melanoma. Metastatic melanoma is defined by the dissemination of primary melanoma cells to distant organs including but not limited to the lymph nodes, lungs, liver, brain, and bone. Great advances have been made in the understanding of melanoma pathogenesis that have resulted in improved disease treatment outcomes including targeted therapies: BRAF and MEK inhibitors and immunotherapies: monoclonal antibodies that target CTLA-4, PD-1 and PD-L1, however not all patients respond, and resistance eventually develops to these agents. This underscores the importance of dissecting the molecular pathways mediating metastasis, the processes of transitioning of an immobile melanoma cell into a motile cell that can successfully colonize distant organs. Melanoma has the highest mutational burden of any cancer as a result of UV induced DNA damage and/or DNA replication errors. After the accumulation of various mutations such as: CDKN2A, TP53, PTEN, and genes encoding SWI/SWF chromatin remodeling complex subunits, primary melanoma enters the invasive phase and becomes malignant melanoma. In addition to the genetic defects associated with metastatic melanoma development there are several dysregulated key signaling pathways that occur during melanoma progression such as the WNT, MAPK, and PI3K/AKT pathways. These pathways are involved in melanoma cell proliferation, growth, survival, evading cell death, and acquiring metastatic properties. During melanoma progression, elevated matrix metallopeptidase (MMP) expression and function have been detected. MMP facilitates the degradation of the ECM that supports melanoma growth during early stages and eventual migration to distant organs. Loss of the ECM enables melanoma cells to become anchorage independent and anoikis resistance that support melanoma dissemination through the circulatory system. In addition to modulations in the expression of cadherins during metastasis, integrins can be modulated to support motility and migration into hospitable metastatic niches by modifying basement membrane interactions, supporting angiogenesis formation and expression of MMPs. Melanoma cells must first dissociate from the primary tumor and undergo Epithelial Mesenchymal Transition (EMT), a process by which epithelial cells undergo morphological and phenotypic changes that allow them to become more migratory and invasive through tissues and enter circulation. Once in circulation, these traveling melanoma cells will migrate to their preferential metastatic organs mediated by chemotaxis of specific chemokine ligand-receptor interactions or by passive migration. If the environment of the metastatic niche is favorable, melanoma cells can successfully colonize there and become clinical detectable tumors.

• #97 Decoding Melanoma Development and Progression: Identification of Therapeutic Vulnerabilities

  https://pmc.ncbi.nlm.nih.gov/articles/PMC7891057/

  Melanoma, a cancer of the skin, arises from transformed melanocytes. Melanoma has the highest mutational burden of any cancer partially attributed to UV induced DNA damage. Diagnosing melanoma in its early stages, in situ, is crucial for the prognosis and survival of this deadly disease as the 5-year survival rate for primary melanoma is 99% and for metastatic melanoma is only 27%. Melanoma patients can be classified into five distinct stages, 0, I, II, III, and IV, as the stage increases the prognosis is worse. Stage 0 is defined as melanoma in situ while stage IV melanoma is known as metastatic melanoma. Metastatic melanoma is defined by the dissemination of primary melanoma cells to distant organs including but not limited to the lymph nodes, lungs, liver, brain, and bone. Great advances have been made in the understanding of melanoma pathogenesis that have resulted in improved disease treatment outcomes including targeted therapies: BRAF and MEK inhibitors and immunotherapies: monoclonal antibodies that target CTLA-4, PD-1 and PD-L1, however not all patients respond, and resistance eventually develops to these agents. This underscores the importance of dissecting the molecular pathways mediating metastasis, the processes of transitioning of an immobile melanoma cell into a motile cell that can successfully colonize distant organs. Melanoma has the highest mutational burden of any cancer as a result of UV induced DNA damage and/or DNA replication errors. After the accumulation of various mutations such as: CDKN2A, TP53, PTEN, and genes encoding SWI/SWF chromatin remodeling complex subunits, primary melanoma enters the invasive phase and becomes malignant melanoma. In addition to the genetic defects associated with metastatic melanoma development there are several dysregulated key signaling pathways that occur during melanoma progression such as the WNT, MAPK, and PI3K/AKT pathways. These pathways are involved in melanoma cell proliferation, growth, survival, evading cell death, and acquiring metastatic properties. During melanoma progression, elevated matrix metallopeptidase (MMP) expression and function have been detected. MMP facilitates the degradation of the ECM that supports melanoma growth during early stages and eventual migration to distant organs. Loss of the ECM enables melanoma cells to become anchorage independent and anoikis resistance that support melanoma dissemination through the circulatory system. In addition to modulations in the expression of cadherins during metastasis, integrins can be modulated to support motility and migration into hospitable metastatic niches by modifying basement membrane interactions, supporting angiogenesis formation and expression of MMPs. Melanoma cells must first dissociate from the primary tumor and undergo Epithelial Mesenchymal Transition (EMT), a process by which epithelial cells undergo morphological and phenotypic changes that allow them to become more migratory and invasive through tissues and enter circulation. Once in circulation, these traveling melanoma cells will migrate to their preferential metastatic organs mediated by chemotaxis of specific chemokine ligand-receptor interactions or by passive migration. If the environment of the metastatic niche is favorable, melanoma cells can successfully colonize there and become clinical detectable tumors.

• #98 Decoding Melanoma Development and Progression: Identification of Therapeutic Vulnerabilities

  https://pmc.ncbi.nlm.nih.gov/articles/PMC7891057/

  Melanoma, a cancer of the skin, arises from transformed melanocytes. Melanoma has the highest mutational burden of any cancer partially attributed to UV induced DNA damage. Diagnosing melanoma in its early stages, in situ, is crucial for the prognosis and survival of this deadly disease as the 5-year survival rate for primary melanoma is 99% and for metastatic melanoma is only 27%. Melanoma patients can be classified into five distinct stages, 0, I, II, III, and IV, as the stage increases the prognosis is worse. Stage 0 is defined as melanoma in situ while stage IV melanoma is known as metastatic melanoma. Metastatic melanoma is defined by the dissemination of primary melanoma cells to distant organs including but not limited to the lymph nodes, lungs, liver, brain, and bone. Great advances have been made in the understanding of melanoma pathogenesis that have resulted in improved disease treatment outcomes including targeted therapies: BRAF and MEK inhibitors and immunotherapies: monoclonal antibodies that target CTLA-4, PD-1 and PD-L1, however not all patients respond, and resistance eventually develops to these agents. This underscores the importance of dissecting the molecular pathways mediating metastasis, the processes of transitioning of an immobile melanoma cell into a motile cell that can successfully colonize distant organs. Melanoma has the highest mutational burden of any cancer as a result of UV induced DNA damage and/or DNA replication errors. After the accumulation of various mutations such as: CDKN2A, TP53, PTEN, and genes encoding SWI/SWF chromatin remodeling complex subunits, primary melanoma enters the invasive phase and becomes malignant melanoma. In addition to the genetic defects associated with metastatic melanoma development there are several dysregulated key signaling pathways that occur during melanoma progression such as the WNT, MAPK, and PI3K/AKT pathways. These pathways are involved in melanoma cell proliferation, growth, survival, evading cell death, and acquiring metastatic properties. During melanoma progression, elevated matrix metallopeptidase (MMP) expression and function have been detected. MMP facilitates the degradation of the ECM that supports melanoma growth during early stages and eventual migration to distant organs. Loss of the ECM enables melanoma cells to become anchorage independent and anoikis resistance that support melanoma dissemination through the circulatory system. In addition to modulations in the expression of cadherins during metastasis, integrins can be modulated to support motility and migration into hospitable metastatic niches by modifying basement membrane interactions, supporting angiogenesis formation and expression of MMPs. Melanoma cells must first dissociate from the primary tumor and undergo Epithelial Mesenchymal Transition (EMT), a process by which epithelial cells undergo morphological and phenotypic changes that allow them to become more migratory and invasive through tissues and enter circulation. Once in circulation, these traveling melanoma cells will migrate to their preferential metastatic organs mediated by chemotaxis of specific chemokine ligand-receptor interactions or by passive migration. If the environment of the metastatic niche is favorable, melanoma cells can successfully colonize there and become clinical detectable tumors.

• #99 Decoding Melanoma Development and Progression: Identification of Therapeutic Vulnerabilities

  https://pmc.ncbi.nlm.nih.gov/articles/PMC7891057/

  Melanoma, a cancer of the skin, arises from transformed melanocytes. Melanoma has the highest mutational burden of any cancer partially attributed to UV induced DNA damage. Diagnosing melanoma in its early stages, in situ, is crucial for the prognosis and survival of this deadly disease as the 5-year survival rate for primary melanoma is 99% and for metastatic melanoma is only 27%. Melanoma patients can be classified into five distinct stages, 0, I, II, III, and IV, as the stage increases the prognosis is worse. Stage 0 is defined as melanoma in situ while stage IV melanoma is known as metastatic melanoma. Metastatic melanoma is defined by the dissemination of primary melanoma cells to distant organs including but not limited to the lymph nodes, lungs, liver, brain, and bone. Great advances have been made in the understanding of melanoma pathogenesis that have resulted in improved disease treatment outcomes including targeted therapies: BRAF and MEK inhibitors and immunotherapies: monoclonal antibodies that target CTLA-4, PD-1 and PD-L1, however not all patients respond, and resistance eventually develops to these agents. This underscores the importance of dissecting the molecular pathways mediating metastasis, the processes of transitioning of an immobile melanoma cell into a motile cell that can successfully colonize distant organs. Melanoma has the highest mutational burden of any cancer as a result of UV induced DNA damage and/or DNA replication errors. After the accumulation of various mutations such as: CDKN2A, TP53, PTEN, and genes encoding SWI/SWF chromatin remodeling complex subunits, primary melanoma enters the invasive phase and becomes malignant melanoma. In addition to the genetic defects associated with metastatic melanoma development there are several dysregulated key signaling pathways that occur during melanoma progression such as the WNT, MAPK, and PI3K/AKT pathways. These pathways are involved in melanoma cell proliferation, growth, survival, evading cell death, and acquiring metastatic properties. During melanoma progression, elevated matrix metallopeptidase (MMP) expression and function have been detected. MMP facilitates the degradation of the ECM that supports melanoma growth during early stages and eventual migration to distant organs. Loss of the ECM enables melanoma cells to become anchorage independent and anoikis resistance that support melanoma dissemination through the circulatory system. In addition to modulations in the expression of cadherins during metastasis, integrins can be modulated to support motility and migration into hospitable metastatic niches by modifying basement membrane interactions, supporting angiogenesis formation and expression of MMPs. Melanoma cells must first dissociate from the primary tumor and undergo Epithelial Mesenchymal Transition (EMT), a process by which epithelial cells undergo morphological and phenotypic changes that allow them to become more migratory and invasive through tissues and enter circulation. Once in circulation, these traveling melanoma cells will migrate to their preferential metastatic organs mediated by chemotaxis of specific chemokine ligand-receptor interactions or by passive migration. If the environment of the metastatic niche is favorable, melanoma cells can successfully colonize there and become clinical detectable tumors.

• #100 Decoding Melanoma Development and Progression: Identification of Therapeutic Vulnerabilities

  https://pmc.ncbi.nlm.nih.gov/articles/PMC7891057/

  Melanoma, a cancer of the skin, arises from transformed melanocytes. Melanoma has the highest mutational burden of any cancer partially attributed to UV induced DNA damage. Diagnosing melanoma in its early stages, in situ, is crucial for the prognosis and survival of this deadly disease as the 5-year survival rate for primary melanoma is 99% and for metastatic melanoma is only 27%. Melanoma patients can be classified into five distinct stages, 0, I, II, III, and IV, as the stage increases the prognosis is worse. Stage 0 is defined as melanoma in situ while stage IV melanoma is known as metastatic melanoma. Metastatic melanoma is defined by the dissemination of primary melanoma cells to distant organs including but not limited to the lymph nodes, lungs, liver, brain, and bone. Great advances have been made in the understanding of melanoma pathogenesis that have resulted in improved disease treatment outcomes including targeted therapies: BRAF and MEK inhibitors and immunotherapies: monoclonal antibodies that target CTLA-4, PD-1 and PD-L1, however not all patients respond, and resistance eventually develops to these agents. This underscores the importance of dissecting the molecular pathways mediating metastasis, the processes of transitioning of an immobile melanoma cell into a motile cell that can successfully colonize distant organs. Melanoma has the highest mutational burden of any cancer as a result of UV induced DNA damage and/or DNA replication errors. After the accumulation of various mutations such as: CDKN2A, TP53, PTEN, and genes encoding SWI/SWF chromatin remodeling complex subunits, primary melanoma enters the invasive phase and becomes malignant melanoma. In addition to the genetic defects associated with metastatic melanoma development there are several dysregulated key signaling pathways that occur during melanoma progression such as the WNT, MAPK, and PI3K/AKT pathways. These pathways are involved in melanoma cell proliferation, growth, survival, evading cell death, and acquiring metastatic properties. During melanoma progression, elevated matrix metallopeptidase (MMP) expression and function have been detected. MMP facilitates the degradation of the ECM that supports melanoma growth during early stages and eventual migration to distant organs. Loss of the ECM enables melanoma cells to become anchorage independent and anoikis resistance that support melanoma dissemination through the circulatory system. In addition to modulations in the expression of cadherins during metastasis, integrins can be modulated to support motility and migration into hospitable metastatic niches by modifying basement membrane interactions, supporting angiogenesis formation and expression of MMPs. Melanoma cells must first dissociate from the primary tumor and undergo Epithelial Mesenchymal Transition (EMT), a process by which epithelial cells undergo morphological and phenotypic changes that allow them to become more migratory and invasive through tissues and enter circulation. Once in circulation, these traveling melanoma cells will migrate to their preferential metastatic organs mediated by chemotaxis of specific chemokine ligand-receptor interactions or by passive migration. If the environment of the metastatic niche is favorable, melanoma cells can successfully colonize there and become clinical detectable tumors.

• #101 Decoding Melanoma Development and Progression: Identification of Therapeutic Vulnerabilities

  https://pmc.ncbi.nlm.nih.gov/articles/PMC7891057/

  Melanoma, a cancer of the skin, arises from transformed melanocytes. Melanoma has the highest mutational burden of any cancer partially attributed to UV induced DNA damage. Diagnosing melanoma in its early stages, in situ, is crucial for the prognosis and survival of this deadly disease as the 5-year survival rate for primary melanoma is 99% and for metastatic melanoma is only 27%. Melanoma patients can be classified into five distinct stages, 0, I, II, III, and IV, as the stage increases the prognosis is worse. Stage 0 is defined as melanoma in situ while stage IV melanoma is known as metastatic melanoma. Metastatic melanoma is defined by the dissemination of primary melanoma cells to distant organs including but not limited to the lymph nodes, lungs, liver, brain, and bone. Great advances have been made in the understanding of melanoma pathogenesis that have resulted in improved disease treatment outcomes including targeted therapies: BRAF and MEK inhibitors and immunotherapies: monoclonal antibodies that target CTLA-4, PD-1 and PD-L1, however not all patients respond, and resistance eventually develops to these agents. This underscores the importance of dissecting the molecular pathways mediating metastasis, the processes of transitioning of an immobile melanoma cell into a motile cell that can successfully colonize distant organs. Melanoma has the highest mutational burden of any cancer as a result of UV induced DNA damage and/or DNA replication errors. After the accumulation of various mutations such as: CDKN2A, TP53, PTEN, and genes encoding SWI/SWF chromatin remodeling complex subunits, primary melanoma enters the invasive phase and becomes malignant melanoma. In addition to the genetic defects associated with metastatic melanoma development there are several dysregulated key signaling pathways that occur during melanoma progression such as the WNT, MAPK, and PI3K/AKT pathways. These pathways are involved in melanoma cell proliferation, growth, survival, evading cell death, and acquiring metastatic properties. During melanoma progression, elevated matrix metallopeptidase (MMP) expression and function have been detected. MMP facilitates the degradation of the ECM that supports melanoma growth during early stages and eventual migration to distant organs. Loss of the ECM enables melanoma cells to become anchorage independent and anoikis resistance that support melanoma dissemination through the circulatory system. In addition to modulations in the expression of cadherins during metastasis, integrins can be modulated to support motility and migration into hospitable metastatic niches by modifying basement membrane interactions, supporting angiogenesis formation and expression of MMPs. Melanoma cells must first dissociate from the primary tumor and undergo Epithelial Mesenchymal Transition (EMT), a process by which epithelial cells undergo morphological and phenotypic changes that allow them to become more migratory and invasive through tissues and enter circulation. Once in circulation, these traveling melanoma cells will migrate to their preferential metastatic organs mediated by chemotaxis of specific chemokine ligand-receptor interactions or by passive migration. If the environment of the metastatic niche is favorable, melanoma cells can successfully colonize there and become clinical detectable tumors.

• #102 Decoding Melanoma Development and Progression: Identification of Therapeutic Vulnerabilities

  https://pmc.ncbi.nlm.nih.gov/articles/PMC7891057/

  Melanoma, a cancer of the skin, arises from transformed melanocytes. Melanoma has the highest mutational burden of any cancer partially attributed to UV induced DNA damage. Diagnosing melanoma in its early stages, in situ, is crucial for the prognosis and survival of this deadly disease as the 5-year survival rate for primary melanoma is 99% and for metastatic melanoma is only 27%. Melanoma patients can be classified into five distinct stages, 0, I, II, III, and IV, as the stage increases the prognosis is worse. Stage 0 is defined as melanoma in situ while stage IV melanoma is known as metastatic melanoma. Metastatic melanoma is defined by the dissemination of primary melanoma cells to distant organs including but not limited to the lymph nodes, lungs, liver, brain, and bone. Great advances have been made in the understanding of melanoma pathogenesis that have resulted in improved disease treatment outcomes including targeted therapies: BRAF and MEK inhibitors and immunotherapies: monoclonal antibodies that target CTLA-4, PD-1 and PD-L1, however not all patients respond, and resistance eventually develops to these agents. This underscores the importance of dissecting the molecular pathways mediating metastasis, the processes of transitioning of an immobile melanoma cell into a motile cell that can successfully colonize distant organs. Melanoma has the highest mutational burden of any cancer as a result of UV induced DNA damage and/or DNA replication errors. After the accumulation of various mutations such as: CDKN2A, TP53, PTEN, and genes encoding SWI/SWF chromatin remodeling complex subunits, primary melanoma enters the invasive phase and becomes malignant melanoma. In addition to the genetic defects associated with metastatic melanoma development there are several dysregulated key signaling pathways that occur during melanoma progression such as the WNT, MAPK, and PI3K/AKT pathways. These pathways are involved in melanoma cell proliferation, growth, survival, evading cell death, and acquiring metastatic properties. During melanoma progression, elevated matrix metallopeptidase (MMP) expression and function have been detected. MMP facilitates the degradation of the ECM that supports melanoma growth during early stages and eventual migration to distant organs. Loss of the ECM enables melanoma cells to become anchorage independent and anoikis resistance that support melanoma dissemination through the circulatory system. In addition to modulations in the expression of cadherins during metastasis, integrins can be modulated to support motility and migration into hospitable metastatic niches by modifying basement membrane interactions, supporting angiogenesis formation and expression of MMPs. Melanoma cells must first dissociate from the primary tumor and undergo Epithelial Mesenchymal Transition (EMT), a process by which epithelial cells undergo morphological and phenotypic changes that allow them to become more migratory and invasive through tissues and enter circulation. Once in circulation, these traveling melanoma cells will migrate to their preferential metastatic organs mediated by chemotaxis of specific chemokine ligand-receptor interactions or by passive migration. If the environment of the metastatic niche is favorable, melanoma cells can successfully colonize there and become clinical detectable tumors.

• #103 Recurrent melanoma: Definition, symptoms, treatment, and more

  https://www.medicalnewstoday.com/articles/recurrent-melanoma

  Melanoma is a type of skin cancer that develops in the cells that give skin its color. A dermatologist can remove and treat melanoma. However, it can return after treatment, becoming recurrent melanoma. […] This type of skin cancer is particularly aggressive, meaning that it can grow and spread to other organs quickly. Recognizing and treating melanoma early can prevent it from returning. However, melanoma can become recurrent if cancer cells survive the original treatment. This means that they may return. […] Most recurrent melanoma develops within 23 years of primary melanoma removal. However, melanoma can recur over 10 years after the original treatment. Remaining melanoma-free for over 10 years reduces the risk of recurrent melanoma, but it may still occur. […] Recurrent melanoma can develop in the same location as the primary melanoma or elsewhere. If melanoma returns, it may appear in the following areas: the surrounding skin and tissue, known as isolated local recurrence; just under the skin or nearby lymph vessels, known as in-transit recurrence; the lymph nodes of the immune system, known as lymph node recurrence; distant organs, known as distant recurrence.

• #104 Recurrent melanoma: Definition, symptoms, treatment, and more

  https://www.medicalnewstoday.com/articles/recurrent-melanoma

  Melanoma is a type of skin cancer that develops in the cells that give skin its color. A dermatologist can remove and treat melanoma. However, it can return after treatment, becoming recurrent melanoma. […] This type of skin cancer is particularly aggressive, meaning that it can grow and spread to other organs quickly. Recognizing and treating melanoma early can prevent it from returning. However, melanoma can become recurrent if cancer cells survive the original treatment. This means that they may return. […] Most recurrent melanoma develops within 23 years of primary melanoma removal. However, melanoma can recur over 10 years after the original treatment. Remaining melanoma-free for over 10 years reduces the risk of recurrent melanoma, but it may still occur. […] Recurrent melanoma can develop in the same location as the primary melanoma or elsewhere. If melanoma returns, it may appear in the following areas: the surrounding skin and tissue, known as isolated local recurrence; just under the skin or nearby lymph vessels, known as in-transit recurrence; the lymph nodes of the immune system, known as lymph node recurrence; distant organs, known as distant recurrence.

• #105 Recurrent melanoma: Definition, symptoms, treatment, and more

  https://www.medicalnewstoday.com/articles/recurrent-melanoma

  The clearest symptom of melanoma is a new spot or lesion on the skin that is changing. The following features of a mole may change: size, shape, color. […] Identifying recurrent melanoma early through regular checkups and self-examinations can help improve their outlook and reduce the effect of further recurrences. […] People who have had melanoma in the past have a higher risk of recurrent melanoma. This type of skin cancer can return after treatment in the same area or spread to nearby lymph nodes and distant organs. A high-stage primary melanoma increases the risk of recurrent melanoma.

• #106 Recurrent melanoma: Definition, symptoms, treatment, and more

  https://www.medicalnewstoday.com/articles/recurrent-melanoma

  Melanoma is a type of skin cancer that develops in the cells that give skin its color. A dermatologist can remove and treat melanoma. However, it can return after treatment, becoming recurrent melanoma. […] This type of skin cancer is particularly aggressive, meaning that it can grow and spread to other organs quickly. Recognizing and treating melanoma early can prevent it from returning. However, melanoma can become recurrent if cancer cells survive the original treatment. This means that they may return. […] Most recurrent melanoma develops within 23 years of primary melanoma removal. However, melanoma can recur over 10 years after the original treatment. Remaining melanoma-free for over 10 years reduces the risk of recurrent melanoma, but it may still occur. […] Recurrent melanoma can develop in the same location as the primary melanoma or elsewhere. If melanoma returns, it may appear in the following areas: the surrounding skin and tissue, known as isolated local recurrence; just under the skin or nearby lymph vessels, known as in-transit recurrence; the lymph nodes of the immune system, known as lymph node recurrence; distant organs, known as distant recurrence.

• #107 Stage 4 Melanoma: Symptoms and Pictures

  https://www.verywellhealth.com/stage-4-melanoma-5101631

  Stage 4 melanoma, otherwise known as metastatic melanoma, is the most advanced form of melanoma, a serious form of skin cancer that begins in cells known as melanocytes. In stage 4, the melanoma has spread to other parts of the body or distant points in the skin. Symptoms vary from person to person, but the most common sign of melanoma is a new or changed mole. Any skin area that appears off in color, shape, size, or texture could also indicate melanoma. Typically, the ABCDE rule is used to identify changes in symmetry, shape, color, and size of the skin lesion. Melanoma tends to be asymmetrical. This means that the two sides of a melanoma will not be the same size or shape. The border or edge of the melanoma is irregular. Instead of a smooth circle or oval like many moles and freckles, the border of a melanoma is often jagged or poorly defined. Melanoma tends to be darker and is most frequently black, brown, and tan. The color is uneven. Other colors are possible; some melanomas are red, gray, white, pink, or blue. Most melanomas are 6 millimeters (about 0.75 of an inch) or bigger and may continue growing. Melanomas typically change in size, shape, and color over time. There may be other symptoms, too. For example, you may experience a change in sensation in a melanoma mole. It may itch or become painful. Metastatic melanoma most often spreads to the lymph nodes, brain, bones, liver, or lungs, and the additional symptoms experienced at this stage depend on where the melanoma has spread: A persistent cough or shortness of breath, headaches or seizures, swelling of the lymph nodes, loss of appetite or unexplained weight loss, bone pain or unusual fractures, nodules or masses in the skin away from the initial melanoma. A person with advanced melanoma may also experience some of the general symptoms of cancer, including hard or swollen lumps, fatigue, weight loss or gain, jaundice, new pain that doesn’t go away, fevers, headaches, cough or hoarseness that lasts, changes in bowel or bladder habits, night sweats, vision or hearing problems, sores or changes in the mouth. Changes in the skin occur throughout all stages of melanoma. The primary tumor may or may not show ulceration at any stage. However, when ulceration is present, the prognosis may be poorer. The thicker the tumor, the greater the chance it will spread. Melanomas with a tumor thickness of less than 1 millimeter generally don’t spread. If the cancer has reached stage 4, it typically presents with a tumor of any thickness that may or may not be ulcerated (any T), with or without spread to the nearby lymph nodes (any N), and with definite spread to distant lymph nodes or organs (M1). Melanoma can recur because screening tests may not catch every cancer cell within the body, and the leftover cells could grow into another tumor. Melanoma has a recurrence rate of around 13.4% in individuals with a previous case of the disease. This recurrence rate is 70.2% within two years of initial diagnosis for people in stages 1 through 3 and 29.8% for those in stage 4.

• #108 Melanoma Warning Signs and Images

  https://www.skincancer.org/skin-cancer-information/melanoma/melanoma-warning-signs-and-images/

  Finding melanoma at an early stage is crucial; early detection can vastly increase your chances for cure. […] Look for anything new, changing or unusual on both sun-exposed and sun-protected areas of the body. Melanomas commonly appear on the legs of women. The number one place they develop on men is the trunk. Keep in mind, though, that melanomas can arise anywhere on the skin, even in areas where the sun doesn’t shine. […] 99% 5-year survival rate for patients in the U.S. whose melanoma is detected early. The survival rate drops to 74% if the disease reaches the lymph nodes and 35% if it spreads to distant organs. […] A is for Asymmetry. Most melanomas are asymmetrical. If you draw a line through the middle of the lesion, the two halves don’t match, so it looks different from a round to oval and symmetrical common mole.

• #109 Melanoma Pictures, Causes, Stages, Symptoms & Survival Rate

  https://www.medicinenet.com/melanoma/article.htm

  Melanoma is a cancer that develops in melanocytes, the pigment cells present in the skin. It can be more serious than the other forms of skin cancer because of a tendency to spread to other parts of the body (metastasize) and cause serious illness and death. About 50,000 new cases of melanoma are diagnosed in the United States every year. […] Early detection and diagnosis are crucial. Caught early, most melanomas can be cured with relatively minor surgery. […] Recurrent melanoma refers to a recurrence of a tumor at the site of removal of a previous tumor, such as in, around, or under the surgical scar. It may also refer to the appearance of metastatic melanoma in other body sites such as skin, lymph nodes, brain, or liver after the initial tumor has already been treated. […] Metastatic melanoma is melanoma that has spread beyond its original site in the skin to distant tissue sites. There are several types of metastatic melanoma. There may be spread through the lymphatic system to local lymph nodes.

• #110 Melanoma Warning Signs and Images

  https://www.skincancer.org/skin-cancer-information/melanoma/melanoma-warning-signs-and-images/

  Finding melanoma at an early stage is crucial; early detection can vastly increase your chances for cure. […] Look for anything new, changing or unusual on both sun-exposed and sun-protected areas of the body. Melanomas commonly appear on the legs of women. The number one place they develop on men is the trunk. Keep in mind, though, that melanomas can arise anywhere on the skin, even in areas where the sun doesn’t shine. […] 99% 5-year survival rate for patients in the U.S. whose melanoma is detected early. The survival rate drops to 74% if the disease reaches the lymph nodes and 35% if it spreads to distant organs. […] A is for Asymmetry. Most melanomas are asymmetrical. If you draw a line through the middle of the lesion, the two halves don’t match, so it looks different from a round to oval and symmetrical common mole.

• #111 Melanoma Symptoms | Logansport Memorial HospitalSearchSearchFacebookYouTubeBlogTwitter

  https://www.logansportmemorial.org/blog/melanoma-symptoms-and-early-detection

  An easy way to remember the signs of melanoma is with the acronym ABCDE: A for Asymmetry. Most melanomas are asymmetrical, meaning if you were to draw a line down the middle of the spot, the two sides wouldn’t match. […] While most moles and skin spots are nothing to worry about, melanomas can be life-threatening. Checking your body regularly for potential melanoma symptoms and seeing a dermatologist yearly for a professional skin exam can help you with early detection and treatment. […] While melanoma is the most dangerous type of skin cancer, early detection and new treatment options greatly improve patient outcomes. […] With early melanoma detection, patients have a 99% 5-year survival rate, according to the Skin Cancer Foundation. […] You know your body best and can often tell when something doesn’t seem right. If you are concerned about any area of your skin, don’t hesitate to get it checked out by an experienced dermatologist.

• #112 Melanoma – Symptoms, Staging & Treatment | MD Anderson Cancer Center

  https://www.mdanderson.org/cancer-types/melanoma.html

  Melanoma appears most commonly on the trunk area in fair-skinned men and on the lower legs in fair-skinned women. In dark-skinned people, melanoma appears most frequently on the palms, the soles of the feet and the skin under nails. If caught early, melanoma is often curable. […] Sun damage, especially a history of peeling sunburns, is the main risk factor for melanoma. Artificial sunlight from tanning beds causes the same risk for melanoma as natural sunlight. […] Having more moles especially 50 or more can increase your risk for melanoma. […] If you have more than 50 moles, you are considered to have a higher risk for skin cancer and could benefit from an annual skin check with a dermatologist. […] If your mole meets any of the ABCDE criteria or follows the Ugly Duckling rule, make an appointment with a dermatologist for a skin cancer screening exam.

• #113 Melanoma Skin Cancer: Images, Diagnosis, and Treatment — DermNet

  https://dermnetnz.org/topics/melanoma

  Melanoma, also referred to as malignant melanoma, is a potentially very serious skin cancer in which there is an uncontrolled growth of melanocytes (pigment cells). […] The first sign of a melanoma is usually an unusual looking freckle or mole and may itch or bleed. Melanomas may grow across the skin (known as the radial growth phase) or grow in depth (known as the vertical growth phase). […] Melanoma may be detected at an early stage when it is only a few millimetres in diameter, but it may grow to several centimetres in diameter before it is diagnosed. […] During its horizontal phase of growth, a melanoma is normally flat. As the vertical phase develops, the melanoma becomes thickened, raised, and palpable. […] Most melanomas have characteristics described by the ABCDE+EFG melanoma criteria or the Glasgow 7-point checklist.

• #114 Stages of Melanoma – AIM at Melanoma Foundation

  https://www.aimatmelanoma.org/stages-of-melanoma/

  Stage 0 melanoma, the malignant tumor is still confined to the upper layer of the skin. The cancer cells are only in the outer layer of the skin (the epidermis) and have not grown any deeper (into the dermis). The melanoma is in situ, which means “in place” in Latin. There is no evidence the cancer has spread to the lymph nodes or distant sites (metastasis). […] In Stage I melanoma, there are cancer cells in both the epidermis and dermis. A Stage I melanoma is up to 2mm thick (Breslow thickness) and may or may not have ulceration. There is no evidence the cancer has spread to lymph nodes or distant sites (metastasis). […] Stage II melanoma is defined by tumor thickness and ulceration. There are cancer cells in both the epidermis and dermis. There is no evidence the cancer has spread to the lymph nodes or distant sites (metastasis).

• #115 Melanoma Skin Cancer: Images, Diagnosis, and Treatment — DermNet

  https://dermnetnz.org/topics/melanoma

  Melanoma, also referred to as malignant melanoma, is a potentially very serious skin cancer in which there is an uncontrolled growth of melanocytes (pigment cells). […] The first sign of a melanoma is usually an unusual looking freckle or mole and may itch or bleed. Melanomas may grow across the skin (known as the radial growth phase) or grow in depth (known as the vertical growth phase). […] Melanoma may be detected at an early stage when it is only a few millimetres in diameter, but it may grow to several centimetres in diameter before it is diagnosed. […] During its horizontal phase of growth, a melanoma is normally flat. As the vertical phase develops, the melanoma becomes thickened, raised, and palpable. […] Most melanomas have characteristics described by the ABCDE+EFG melanoma criteria or the Glasgow 7-point checklist.

• #116 How fast does melanoma spread, and how dangerous is it?

  https://www.medicalnewstoday.com/articles/how-fast-does-melanoma-spread

  Melanoma is a type of skin cancer that can spread rapidly to other areas. However, there are also slow-growing types that may develop over many years. […] Melanoma can spread quickly, but the prognosis depends on the type of melanoma a person has, how advanced it is, and the persons overall health. […] Some melanomas can spread within a few months, while others may grow more slowly. It is not possible to predict how quickly melanoma will progress with certainty. […] Symptoms that melanoma has metastasized to other tissues and organs will depend on where the cancer has spread but may include: enlarged lymph nodes, unexplained weight loss, a persistent cough or difficulty breathing, bone pain, neurological symptoms, such as headaches, seizures, or vision changes. […] Melanoma can present in various ways, but common symptoms include: new moles, growths, or spots on the skin; changes in an existing mole, such as its size, shape, color, or texture; moles that bleed, itch, or hurt; moles with multiple colors or an uneven distribution of color. […] Melanoma is a potentially aggressive form of skin cancer that can spread rapidly if doctors do not detect and treat it early. Recognizing its symptoms and seeking prompt medical attention is crucial for optimizing a persons outlook.

• #117 Melanoma Skin Cancer: Images, Diagnosis, and Treatment — DermNet

  https://dermnetnz.org/topics/melanoma

  The risk of spread and ultimate death from invasive melanoma depends on several factors, including anatomic location, pathologic factors, and mutation status. However, the main factor is the Breslow thickness of the melanoma at the time it was surgically removed. […] Metastases are rare for melanomas < 0.75 mm in size, and the risk associated with tumours 0.75–1 mm thick is about 5%. The risk steadily increases with thickness so that melanomas > 4 mm have a risk of metastasis of about 40%.

• #118 Melanoma | Canadian Cancer Society

  https://cancer.ca/en/cancer-information/cancer-types/melanoma-skin

  Common signs and symptoms of melanoma skin cancer include a new mark on the skin and a mole that changes size, shape, colour or height. […] Melanoma skin cancer can spread (metastasize) to the lymph nodes, lung and liver. […] Prognosis estimates the outcome for melanoma skin cancer. It depends on many factors including the thickness of the tumour and how fast the cancer cells are growing.

• #119

  https://myhealth.alberta.ca/Health/medications/pages/conditions.aspx?hwid=hw206547&lang=en-ca

  The most important warning sign for melanoma is any change in size, shape, or colour of a mole or other skin growth, such as a birthmark. Watch for changes that occur over a period of weeks to a month. […] The most important warning sign for melanoma is a change in size, shape, or colour of a mole or other skin growth (such as a birthmark). Call your doctor if you have: Any change in a mole, including size, shape, colour, soreness, or pain. […] With metastatic melanoma, the symptoms may be vague. And any symptoms will likely depend on where the melanoma has spread in the body. Symptoms may include swollen or painful lymph nodes, lumps under the skin, an ongoing cough, swelling or pain in the belly, headaches, or unexplained weight loss. […] Melanoma can spread (metastasize). It most often spreads first into nearby lymph nodes. It can also spread through the bloodstream to the skin, liver, lungs, bone, and brain. […] When melanoma is found early, it can often be cured by surgery to remove it. But after melanoma spreads, it is harder to cure.

• #120 Decoding Melanoma Development and Progression: Identification of Therapeutic Vulnerabilities

  https://pmc.ncbi.nlm.nih.gov/articles/PMC7891057/

• #121 Decoding Melanoma Development and Progression: Identification of Therapeutic Vulnerabilities

  https://pmc.ncbi.nlm.nih.gov/articles/PMC7891057/

Zobacz więcej